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Epidemiological evidence links an individual’s susceptibility to chronic disease in adult 106 
life to events during their intrauterine phase of development. Biologically this should 107 
not be unexpected, for organ systems are at their most plastic when progenitor cells are 108 
proliferating and differentiating.  Influences operating at this time can permanently 109 
affect their structure and functional capacity, and the activity of enzyme systems and 110 
endocrine axes. It is now appreciated that such effects lay the foundations for a diverse 111 
array of diseases that become manifest many years later, often in response to secondary 112 
environmental stressors. Fetal development is underpinned by the placenta, the organ 113 
that forms the interface between the fetus and its mother. All nutrients and oxygen 114 
reaching the fetus must pass through this organ. The placenta also has major endocrine 115 
functions, orchestrating maternal adaptations to pregnancy and mobilising resources 116 
for fetal use. In addition, it acts as a selective barrier, creating a protective milieu by 117 
minimizing exposure of the fetus to maternal hormones, such as glucocorticoids, 118 
xenobiotics, pathogens and parasites. The placenta shows a remarkable capacity to 119 
adapt to adverse environmental cues and lessen their impact on the fetus. However, if 120 
placental function is impaired, or its capacity to adapt is exceeded, then fetal 121 
development may be compromised. Here, we explore the complex relationships 122 
between the placental phenotype and developmental programming of chronic disease in 123 
the offspring. Ensuring optimal placentation offers a new approach to the prevention of 124 
disorders such as cardiovascular disease, diabetes, and obesity, which are reaching 125 
epidemic proportions. 126 
 127 
  128 
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I.  INTRODUCTION 129 
 130 
The intrauterine phase of development is key to life-long health, for the foundations of 131 
the body plan and the major organ systems are laid down during this period. 132 
Perturbation of gene expression or cell proliferation and differentiation during 133 
vulnerable periods by nutritional and other environmental influences can alter the 134 
structure and functional capacity of major organ systems for life, a process known as 135 
developmental programming. These changes predispose the offspring to a variety of 136 
disorders that may become manifest in later life, often following exposure to a second 137 
precipitating challenge. This concept has profound implications for public health and 138 
our approach to the management of chronic diseases, some of which are now reaching 139 
epidemic proportions.  140 
 141 
The programmed outcomes and the mechanisms by which they occur in the developing 142 
fetus, together with their significance for future health have been reviewed previously 143 
(37, 56, 215, 237, 374, 426, 528, 565). Here, we focus on the impact of the placenta, the 144 
organ that forms the interface between the mother and her offspring while in utero, on 145 
the causation of chronic disease. The placenta evolved to transfer nutrients to the fetus, 146 
and also to create a stable milieu in which the fetus can develop, isolated as far as 147 
possible from maternal and environmental stressors. To achieve these functions, it 148 
performs a remarkably diverse range of activities, including active and passive 149 
transport, endocrine secretion, immunological protection and xenobiotic detoxification. 150 
As well as being multifunctional, the placenta is also a remarkably plastic organ, capable 151 
of considerable structural and functional adaptations that help to mitigate adverse 152 
maternal insults, such as nutrient deprivation, and exposure to drugs, toxins or hypoxia.  153 
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However, if normal placental function is impaired, or the organ’s capacity for adaptation 154 
exceeded, then the fetal milieu may be perturbed with major consequences for the life-155 
long health of the offspring (Figure 1). Ensuring women of childbearing age have access 156 
to sufficient and appropriate nutrition is essential, but so too is an understanding of 157 
maternal physiological adaptations during pregnancy, in particular the mechanisms by 158 
which resources are allocated such that her own needs, and those of her offspring, are 159 
suitably met. There is now compelling evidence that the placenta plays a central role in 160 
orchestrating this process.  161 
 162 
In order to achieve our aim we will consider: 1) the various functions of the mammalian 163 
placenta, 2) how placental structure and development facilitate those functions in the 164 
human and in the two main experimental models, the mouse and the sheep, 3) the 165 
epidemiological evidence linking changes in human placental phenotype to adult 166 
disease, 4) the mechanisms by which placental cells may sense oxygen and nutrient 167 
availability, 5) how maternal nutrient supply and fetal demand may be integrated at the 168 
placental interface, 6) the mechanisms by which the placenta can impact on 169 
developmental programming of the offspring, and finally, 7) areas for future research. 170 
 171 
 We start by briefly describing the general concept of developmental programming of 172 
chronic disease. 173 
 174 
II.  DEVELOPMENTAL PROGRAMMING OF CHRONIC DISEASE 175 
 176 
It has long been known that the intrauterine environment has a major impact on 177 
development of the adult phenotype (558), but the significance of this phenomenon for 178 
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adult health was first highlighted by David Barker and colleagues. In the late 1980s, they 179 
reported on ~15,000 records from men and women in Hertfordshire, UK, and showed 180 
that rates of death from ischemic heart disease were ordered across the birth weight 181 
scale (40).  Babies born at the lower end of the scale (5 lb or 2.3 kg) had the highest 182 
mortality rates as adults, while those at the opposite end (9 lb or 4.0 kg) were two-thirds 183 
lower. At the time, Barker and his colleagues had just concluded a study examining 184 
cardiac-related death rates across England (31). The finding that people in the industrial 185 
areas of the north of the country died more often of cardiovascular disease than those in 186 
the rural south was not surprising, since the impact of an adverse social environment on 187 
mortality was already known.  The new insight gained was that their findings showed a 188 
similar geographic distribution as for the death rates of neonates some sixty years 189 
earlier.  190 
 191 
The Barker team reasoned that both the neonates and adults died for the same reason, 192 
namely that their development had been compromised before birth. Thus, they 193 
suggested that an adverse intrauterine environment rendered them vulnerable to death 194 
as neonates, and more likely to acquire heart disease later if they survived childhood 195 
(33). This relationship between poor growth in the womb and the risk of adult disease 196 
has since been confirmed in many other countries, including Finland (26), Sweden 197 
(332), China (183), India (517), and the USA (464).  198 
 199 
The conclusion that growth rates before birth predict later disease was initially received 200 
with skepticism, principally because a mechanistic explanation was not immediately 201 
apparent.  Eventually, however, experimental evidence accumulated showing clear 202 
biological links between stresses that occurred during the first 1000 days after 203 
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conception and elevated risks for chronic conditions.  These links revolve around 204 
permanent structural changes in organ systems, premature aging of tissues and 205 
epigenetic changes. For example, a growth-restricted fetus has smaller coronary arteries 206 
(288), fewer but more immature cardiomyocytes (55, 348, 394), less elastin in the 207 
arteries (152, 362, 526), and fewer nephrons in the kidney (22, 352).  In addition, the 208 
pancreas has fewer insulin-producing beta cells and reduced vascularization (159, 340, 209 
473), and the structure and maturation of the brain (142), lungs (358, 359, 424, 460) 210 
and liver (209, 474) are compromised.  All these outcomes have been linked 211 
experimentally to impaired placental function. These links go beyond an abnormal 212 
maternal nutrient supply, and include, for example, intrauterine hypoxia (213), 213 
maternal social stress of the severity that leads to hypercortisolemia (128) and, 214 
increasingly, environmental toxins.  Thus, diverse stressors acting alone or in 215 
combination can lead to alterations in fetal development. Developmental plasticity is a 216 
well-described process in nature (43), but little research has addressed the 217 
phenomenon within the placenta. This is an area ripe for study. 218 
 219 
The placenta does not function in isolation, however, and the mother’s nutritional status 220 
has a powerful modifying influence on allocation of resources.  Accumulating data show 221 
that maternal size, a marker of the mother’s own growth history, and body composition, 222 
a marker of her current nutritional state, combine with placental size and shape to 223 
predict chronic disease outcomes. This is perhaps not surprising given that a proportion 224 
of the nutrients that support fetal growth, particularly in late pregnancy, come from 225 
turnover of maternal fat reserves that are built up in early pregnancy (414). More 226 
research is needed to understand how mothers and their offspring communicate 227 
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through the placenta to regulate nutrient flow so that the needs of both parties are 228 
adequately met.  229 
 230 
III. FUNCTIONS OF THE PLACENTA 231 
 232 
When considering the potential impact that perturbation of placental function may have 233 
on developmental programming, it is essential to bear in mind the variety of activities 234 
that the organ performs. Different stressors, for example undernutrition or hypoxia, may 235 
affect different placental functions, either in isolation or across the range. Here we 236 
consider those functions that have the greatest impact on the embryonic/fetal milieu, 237 
namely the transport of nutrients and respiratory gases, the secretion of hormones, and 238 
its action as a selective barrier.  239 
 240 
A. Transport of nutrients and mechanisms 241 
Although a wide diversity of morphological types exists amongst mammals, a common 242 
feature is that the placenta provides for an extensive and intimate apposition of the 243 
maternal and fetal circulations. The tissue separating the two circulations is best 244 
referred to generically as the interhemal membrane, and it may vary in the number and 245 
nature of its cell layers (583). Transport across the membrane has recently been 246 
extensively reviewed (19, 61, 95), and so this account is restricted to those aspects most 247 
pertinent to placental adaptations to environmental cues.  248 
  249 
There are three main mechanisms by which exchange across the interhemal membrane 250 
can take place; diffusion, transporter-mediated mechanisms and endocytosis/exocytosis 251 
(Figure 2).  252 
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 253 
1. Diffusion 254 
Simple diffusion is the passage of molecules through the lipid bilayers of the cell 255 
membranes and the intervening cytoplasm, and is a passive process that does not 256 
involve the expenditure of ATP. For small uncharged molecules the rate of diffusion is 257 
governed by Fick’s Law of diffusion, being proportional to the surface area for exchange 258 
and inversely proportional to the thickness of the interhemal membrane: 259 
 260 
𝑅𝑎𝑡𝑒 =  
𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 ×  𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑔𝑟𝑎𝑑𝑖𝑒𝑛𝑡 ×  𝐾𝑟𝑜𝑔ℎ′𝑠 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡
𝑡ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠 𝑜𝑓 𝑖𝑛𝑡𝑒𝑟ℎ𝑎𝑒𝑚𝑎𝑙 𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒
 
  where Krogh’s constant is a measure of the diffusivity of the molecule 261 
 262 
Small hydrophobic molecules cross cell membranes easily, and so their transplacental 263 
flux depends principally on the concentration gradient driving exchange. The main 264 
factor maintaining that gradient is the rate of circulation of blood on either side of the 265 
membrane, refreshing and depleting the reservoir and recipient pools respectively.  266 
Hence, exchange of molecules such as the respiratory gases and lipophilic drugs is 267 
considered to be ‘flow-limited’, and changes in maternal or fetal blood flow have a 268 
profound impact on the net flux (573). However, under limiting conditions, such as 269 
pregnancy at high altitude, changes in surface area or membrane thickness may be 270 
considered adaptive responses to facilitate exchange (275, 369, 458). By contrast, more 271 
hydrophilic molecules traverse lipid bilayers slowly, and so the transmembrane 272 
concentration gradient is generally more stable. Exchange of these molecules is said to 273 
be ‘membrane- or  ‘diffusion’-limited, and structural parameters such as surface area 274 
and membrane thickness will play a more major role in determining the flux.  275 
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 276 
Another mechanism influencing diffusion across the interhemal membrane is the 277 
presence of water-filled channels or pores. These are most relevant in species where the 278 
trophoblastic layer of the membrane is syncytial in nature and there are no paracellular 279 
pathways available, such as the human and mouse. The presence of such pores is 280 
evidenced by data showing that the human placenta is permeable to solutes of up to 281 
5,200 daltons (529, 575). Changing the number or diameter of these pores represents a 282 
potential mechanism by which the diffusion characteristics of the membrane could be 283 
altered in response to environmental cues. Identifying the morphological correlates of 284 
these pores has proved problematic in the human due to the complexity of the 285 
syncytiotrophoblast. Occasional membrane-lined clefts resembling intercellular spaces 286 
have been reported, but may represent areas of repair (339). However, the apical 287 
portions of such clefts are sealed by tight junctions and are impenetrable to the 288 
extracellular marker ruthenium red instilled at the time of post-fixation. Another 289 
approach has been to perfuse the fetal vasculature of the placenta at elevated pressures. 290 
Pressures of 100 mmHg and above cause dilation of basal invaginations of the 291 
syncytiotrophoblast, and enlargement of vacuoles within the syncytioplasm (304), but  292 
connections with the apical surface are not found. Hence, the physiological significance 293 
of these morphological observations remains uncertain. An alternative explanation for 294 
the apparent existence of pores is that localized areas of damage to the 295 
syncytiotrophoblast represent paracellular routes of transport (68). These are discussed 296 
in more detail in Section III.C.1. 297 
 298 
2. Transporter-mediated mechanisms 299 
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 Transporter-mediated processes are dependent on carrier proteins being inserted into 300 
cell membranes to facilitate the passage of highly hydrophilic molecules (Figure 2). 301 
Although contrasting in their functional characteristics, they are characterized by 302 
common features such as substrate specificity, saturation kinetics and the ability to be 303 
competitively inhibited (19). Some transporter proteins are also capable of pumping 304 
against a concentration gradient, utilizing ATP. As will be discussed later, there is 305 
considerable evidence indicating that expression of the transporter proteins, and their 306 
insertion into the appropriate membrane are responsive to nutritional and hormonal 307 
cues. This flexibility allows the placenta to adapt functionally, independent of structural 308 
changes. Transporter-mediated processes are responsible for the exchange of key 309 
nutrients such as glucose, amino acids and fatty acids as outlined below. In addition, 310 
there are a variety of other transporter proteins localized to the apical surface of the 311 
syncytiotrophoblast in the human, including ones specific for micronutrients, such as 312 
copper, iron and folate (49, 371).  313 
 314 
i. Glucose 315 
Transport of glucose and related hexoses is dependent on the GLUT family of 316 
transporters that enable the sugar to pass down a concentration gradient at rates up to 317 
10,000 times faster than possible by simple diffusion (169). Hence, it is commonly 318 
referred to as facilitated diffusion. The density of glucose transporter proteins is 319 
considerably greater on the apical surface of the syncytiotrophoblast of the human 320 
placenta than on the basal surface, which is thought to reflect the fact that much of the 321 
glucose taken up from the maternal circulation is used to meet the placenta’s own 322 
considerable metabolic needs (141, 270). It is likely, therefore, that the density of the 323 
transporters on the basal surface represents the rate-limiting step for exchange. In the 324 
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human, GLUT1 is the principal isoform involved in transport across the trophoblast, and 325 
protein levels in the apical membrane of the syncytiotrophoblast remain constant from 326 
16 weeks until term. By contrast, levels in the basal membrane double during the late 327 
second trimester (280), and this change may explain the increase in glucose transport 328 
seen towards term. GLUT1 in the placenta is insensitive to insulin.  329 
 330 
GLUT3 is also present on the apical, but not the basal, membrane of the 331 
syncytiotrophoblast (67), and is the principal isoform on fetal capillary endothelial cells 332 
(245, 270). It has a higher affinity for glucose than GLUT1, and may be more important 333 
for transport during early pregnancy (67). In the murine placenta, GLUT1 has been 334 
immunolocalized at the ultrastructural level to the apical surface of layer II of the 335 
syncytiotrophoblast and the basal surface of layer III (409), suggesting these layers may 336 
operate in terms of glucose transport as one functional unit. Both GLUT1 and GLUT3 are 337 
expressed in the sheep placenta, but in different layers of the interhemal membrane (95, 338 
582). GLUT1 is localized to the basal surfaces of the maternal-fetal synepithelium and 339 
the fetal trophoblast, while GLUT3 is present on the apical surface of the trophoblast. 340 
Therefore, a glucose molecule must interact with the two isoforms sequentially to 341 
transit between the circulations. Expression of GLUT1 and GLUT3 increases across 342 
gestation in the sheep, but the ratio alters with GLUT3 becoming more predominant 343 
towards term (165). The implications for glucose transport are not obvious, but clearly 344 
caution needs to be exercised when extrapolating data across species (270).  345 
 346 
ii. Amino acids 347 
Amino acid transport across the placenta is a key determinant of fetal growth as it 348 
provides the essentials for protein synthesis. Single amino acids diffuse slowly across 349 
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cell membranes, and most uptake is mediated by a large family of transporter proteins. 350 
Amino acid transporters can be classified according to their properties, for example 351 
whether they are sodium-coupled or not, and whether they convey neutral, cationic or 352 
aromatic amino acids (19, 113). Alternatively, on a more functional basis they fall into 353 
three broad categories, accumulative, exchange and facilitative that interact to modulate 354 
net transfer across the placenta against a concentration gradient (335).  Accumulative 355 
transporters are present on both the apical and basal cell membranes of the trophoblast, 356 
and mediate the uptake of amino acids driven by the intra-extracellular electrochemical 357 
gradient previously described. These transporters generate a pool of amino acids within 358 
the trophoblast that drives the activity of other transporters. Efflux from the basal 359 
membrane is performed by facilitative transporters, and the rate is determined 360 
principally by the concentration gradient across the membrane. The gradient for specific 361 
amino acids is modulated by the action of exchange transporters, which, as their name 362 
suggests, exchange an amino acid of one type in the intracellular pool generated by the 363 
accumulative transporters for an amino acid of another type.  Hence, interaction 364 
between the three groups of transporters is required to effect transfer, and the net flux 365 
per unit area will be dependent upon the, density of the transporter proteins in the 366 
apical and basal membranes, the metabolic and anabolic demands of the intervening 367 
trophoblastic cytoplasm, and the rate of blood flow in the two circulations.  368 
 369 
iii. Lipids 370 
Lipids are essential for the formation of cell membranes, and may be an important fuel 371 
for fetal growth, especially among Asian Indians (319). Triglycerides cannot cross the 372 
placenta, but may be conveyed in lipoproteins. A number of binding sites for 373 
lipoproteins have been identified on the apical and basal membranes of the 374 
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syncytiotrophoblast, including those for very low density (VLDL-R) (580), low density 375 
(LDL-R) (179), and high density lipoproteins (HDL-R) (9). The scavenger receptors SR-376 
B1 and CLA-1 that bind LDL and HDL respectively are also present (179, 322). 377 
Expression of the mRNAs encoding the VLDL-R and LDL-R increases across gestation 378 
(402, 580), but is suppressed at term in pregnancies complicated by pre-eclampsia and 379 
severe growth restriction (402, 552). The impact of these changes is uncertain, as is, 380 
indeed, the contribution of lipoprotein uptake to overall lipid transport. However, 381 
placental lipoprotein uptake represents an important step in the maternal-fetal transfer 382 
of cholesterol (584).  383 
 384 
Alternatively, triglycerides can be converted into free fatty acids (FFAs) by the actions of 385 
lipases. Endothelial lipase and lipoprotein lipase have been immunolocalized to the 386 
apical membrane of the syncytiotrophoblast during the first trimester, although only the  387 
former is seen at term (208). The mRNA encoding endothelial lipase is notably lower in 388 
growth-restricted placentas compared to normal counterparts (208), but the 389 
significance of this finding for transfer of FFAs is not known. The mechanisms 390 
underlying transport of FFAs across the placenta are not fully understood, but at least 391 
three membrane systems have been implicated that may act in concert, in addition to 392 
simple diffusion.  A family of fatty acid transport proteins, (FATP 1-6), have been 393 
identified in plasma membranes of the human placenta (162). These are particularly 394 
important for transfer of medium to long chain fatty acids. Targeted deletion of FAT-4 395 
results in embryonic lethality, but little is known regarding the specificity of the 396 
different transporters. There is also a fatty acid binding protein (FABPpm) located in the 397 
apical membrane of the syncytiotrophoblast that appears to preferentially bind and 398 
transport long chain polyunsaturated fatty acids. Finally, fatty acid translocase 399 
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(FAT/CD36) is present in both the apical and basal membranes of the 400 
syncytiotrophoblast. Expression of these transporters is responsive to nutrient 401 
availability through fatty acid activated transcription factors (PPARs, LXR, PXR and 402 
SREBP-1) (162), and is also influenced by maternal obesity (156). 403 
 404 
Computational modeling has suggested that transport of fatty acids across the placenta 405 
is modulated by the presence of an intracellular metabolic pool (438), which had been 406 
assumed to be within the syncytiotrophoblast. However, recent data derived from 407 
placental explants demonstrate that esterification of long-chain fatty acids and their 408 
incorporation into lipid droplets occurs within the cytotrophoblast cells, and not the 409 
syncytium (314). Further research into the role of the cytotrophoblast cells in lipid 410 
transfer to the fetus is therefore clearly required.  411 
 412 
3. Endocytosis/exocytosis 413 
Endocytosis/exocytosis is the final mechanism for transplacental transport (Figure 2). 414 
Immunoglubulin G (IgG), other large proteins, and cholesterol are considered to be 415 
transported by this route. Early studies suggested IgG binds to the apical membrane of 416 
the syncytiotrophoblast surface and then concentrates in clathrin-coated pits. However, 417 
further work has indicated that IgG is internalized initially through non-specific 418 
endocytosis, and delivered, along with other proteins, to early endosomes (486). In the 419 
acidic microenvironment, IgG binds to the neonatal Fc receptor, FcRn, which routes it 420 
for transcytosis and exocytosis at the basal membrane. There, the more neutral pH of 421 
the interstitial fluid favors release of the IgG, promoting transport into the fetal 422 
circulation. In this way, a proportion of the IgG internalized is protected from lysosomal 423 
degradation, and specificity of transport of Ig subclasses is conferred. 424 
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 425 
 Endocytosis of macro- and micro-nutrients is particularly important in the yolk sac of 426 
rodents during the period of early organogenesis (18, 45, 617). The multifunctional 427 
endocytic receptors megalin and cubilin have been immunolocalized to the visceral 428 
endoderm layer of the rodent yolk sac (13, 186), and potential ligands include folic acid, 429 
retinoic acid, vitamins B12 and D, cholesterol, insulin and aminoglycosides (110). 430 
Targeted disruption of these receptors leads to failure of somite formation, indicating 431 
their key role in supporting early embryogenesis (506).  Endocytic uptake of maternal 432 
proteins has been described in the human syncytiotrophoblast (325, 571), and is 433 
particularly prominent during the first trimester when maternal glycoproteins secreted 434 
by the endometrial glands, such as MUC-1 and glycodelin, are engulfed (83).  A large 435 
proportion of the endosomes co-localize immunohistochemically with lysosomes (83), 436 
but some maternal glycodelin crosses the placenta intact and accumulates in the 437 
amniotic fluid (296). Megalin and cubilin are expressed in the syncytiotrophoblast, and 438 
are also present in the yolk sac, raising the possibility that it too may play a role in 439 
nutrient exchange during the earliest stages of human pregnancy (72).  440 
 441 
B. Endocrine functions 442 
The importance of the placenta’s endocrine role is reflected in the fact that many of the 443 
large-placenta-specific gene families arising during evolution through gene duplication 444 
encode hormones (450).  A wide array of hormones is secreted from the placenta with 445 
major impacts on maternal physiology, ranging from suppression of reproductive cycles 446 
to mobilization of nutrient resources. The evolution and function of the principal 447 
placental hormones was reviewed by Carter (95). 448 
 449 
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In the earliest stages of pregnancy, the most important function is to signal the presence 450 
of the conceptus to the mother, and prevent onset of the next ovarian cycle. In the 451 
human chorionic gonadotropin (hCG) secreted by the syncytiotrophoblast acts via 452 
luteinizing hormone receptors to maintain progesterone output from the corpus luteum. 453 
In the sheep, secretion of interferon τ by the conceptus blocks endometrial production 454 
of the luteolytic prostaglandin F2α, and so establishes pregnancy. Continuing high levels 455 
of progesterone keep the myometrium in a quiescent state, and in the human prevent 456 
menstruation.  457 
 458 
There is strong evidence in the sheep and other domestic species that interferon τ 459 
performs additional functions, combining with placental lactogens secreted by the 460 
trophoblast to upregulate the expression of genes encoding uterine milk proteins and 461 
growth factors in the endometrial glands (514). This signaling loop represents a 462 
mechanism by which the trophectoderm is able to enhance the nutrient supply to the 463 
conceptus, and stimulate early development of the placenta. Circumstantial evidence 464 
suggests that an equivalent mechanism may operate in the human based on hCG and 465 
placental lactogen from the trophoblast (76), but details of the pathways involved are 466 
not available as yet.  467 
 468 
Progesterone also stimulates maternal appetite during early pregnancy, as does human 469 
placental lactogen (hPL), enabling the deposition of maternal adipose energy reserves 470 
that can be utilized later in pregnancy and during lactation (414). This build-up is 471 
facilitated by the development of leptin-resistance (321), which prevents the negative 472 
feedback on appetite centers in the hypothalamus that would normally occur as leptin 473 
levels rise with fat accumulation.  Evidence from rodent models suggests this central 474 
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resistance may be mediated by placental lactogens. Deposition of fat reserves is also 475 
facilitated by increased levels of insulin secretion following stimulation of pancreatic ß 476 
cell proliferation by placental lactogens in early pregnancy. 477 
 478 
Later in pregnancy, a state of insulin resistance develops in the peripheral maternal 479 
tissues, mediated, in part, through the actions of placental growth hormone (23). There 480 
is also an accompanying rise in circulating triglycerides and free fatty acids.  This may 481 
serve to enhance nutrient transfer to the fetus by elevating the concentration gradients 482 
across the villous membrane, particularly after meals. The placenta may further 483 
stimulate its own development by the action of placental growth hormone on the 484 
secretion of insulin-like growth factor 1 (IGF-1) by the maternal liver. IGF-1 is a 485 
powerful mitogen that increases placental cell proliferation, and increases maternal 486 
blood flow to the organ (196, 494). 487 
 488 
Finally, it is important to note that the placenta secretes a number of hormones that are 489 
traditionally associated with the hypoxic kidney, including erythropoietin, angiotensin II 490 
and adrenomedullin (123, 357). Erythropoietin, in particular, is synthesized at rates far 491 
higher than the fetal kidney, and may mediate both classical hematopoietic responses to 492 
hypoxia and non-classical changes, including increased placental vascularity and 493 
defense against oxidative stress (534).  494 
 495 
C. Protective functions of the placenta 496 
As well as facilitating the transport of nutrients to the fetus, the placenta plays an 497 
equally important role in minimizing xenobiotics, inorganic toxins, pathogens and also 498 
maternal hormones from reaching the fetus. It therefore acts as a selective barrier to 499 
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create an internal milieu in which the fetus, and in particular its endocrine systems, can 500 
develop independently.  Nonetheless, perturbations of this function due to mechanical 501 
damage, polymorphisms (267), or environmental factors (287), may lead to increased 502 
fetal exposure.  A range of drugs and toxins are well known to disrupt normal 503 
development and mediate teratogenesis, and one might speculate that lower doses, 504 
insufficient to cause malformations, may play a role in programming. 505 
 506 
1. A Physical barrier 507 
The syncytiotrophoblast is often cited as a physical barrier, impeding the entry of 508 
pathogens and maternal immune cells into the fetal compartment. Whilst this is true, 509 
defects in the surface are seen in all pregnancies and represent potential portals of 510 
entry. These defects, usually 10-20 µm in diameter, can arise through physical 511 
interactions between neighboring villi, or the rupture of syncytial bridges that form 512 
between terminal villi (73). Abnormal hemodynamics within the intervillous space as a 513 
result of deficient conversion of the spiral arteries may also cause damage to the 514 
syncytium (265). Defects in the villous surface stimulate activation of maternal platelets 515 
and deposition of fibrin (82).  These deposits, which are seen in all pregnancies (367), 516 
have been demonstrated to be permeable to creatinine and so may represent sites of 517 
paracellular transport through the syncytiotrophoblast (68). They are also potential 518 
portals for infectious agents; indeed, incubation of placental villi with listeria in vitro 519 
revealed that the bacteria are only able to penetrate at sites where the 520 
syncytiotrophoblast is damaged or absent (465).  Despite these defects, the majority of 521 
pathogens and parasites do not cross the placenta, most likely due to the large number 522 
of marcophages within the villous stroma. These are actively phagocytic, and generally 523 
only those pathogens that can survive within the macrophages are associated with 524 
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vertical transmission in utero  (345, 346). Infection of the fetus can lead to growth 525 
restriction (3), and hence developmental programming. 526 
 527 
 2. Efflux transporters 528 
Efflux transporters, such as members of the multidrug resistance protein family, the 529 
breast cancer resistance protein, P-glycoprotein, organic anion (OAT and OATP) and 530 
cation (OCTN) transporters, and the noradrenalin and serotonin transporters are 531 
present on the apical and basal surfaces of the syncytiotrophoblast and the fetal 532 
endothelial cells in the human placenta (20, 407, 500, 540).  These transporters aid the 533 
efflux of a broad range of anionic and cationic organic compounds, and are thought to 534 
provide protection to the fetus from maternally-administered drugs and exposure to 535 
environmental chemicals. The mRNA and protein levels of P-glycoprotein reduce across 536 
gestation, suggesting the fetus may be more exposed to toxic insults later in pregnancy 537 
(519).  538 
 539 
Assessing the efficacy of these mechanisms in preventing placental transfer is difficult in 540 
the human, and in the clinical setting is limited to correlative studies. Thus, during the 541 
first trimester the teratogenic effects of drugs that are targets of P-glycoprotein is 542 
greater if they are administered in combination with other P-glycoproteins substrates 543 
than by themselves, suggesting competitive interactions at the level of the transporter 544 
(140). Other studies have compared maternal and fetal blood levels at the time of 545 
delivery; for example, levels of dioxins in the fetal circulation were found to be 546 
approximately half those in the mother (536). Experimentation is obviously possible in 547 
animal models, but species differences in the expression of efflux transporters raises 548 
questions as to the applicability of the resultant data to the human (406). 549 
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 550 
Dual-perfusion of the delivered placenta provides an experimental system, albeit 551 
technically challenging, in which to explore transfer of drugs and toxins (266, 408). 552 
Comparison of the data with maternal-fetal in vivo measurements has validated transfer 553 
for approximately 50 drugs (266). In addition, the system is manipulable; for example, 554 
inhibition of G-glycoprotein increases transfer of the antiretroviral drugs lopinavir and 555 
retinavir to the fetal perfusate, confirming its role as an efflux transporter (100).  556 
 557 
3. Enzymatic defenses 558 
 A range of defensive enzymes capable of detoxifying xenobiotics and drugs is present 559 
within the syncytioplasm. This includes cytochrome P450 enzymes, alcohol 560 
dehydrogenase, glutathione transferase and (407). These enzymes provide a measure of 561 
defense against agents such alcohol and components of cigarette smoke, but can be 562 
overwhelmed, as evidenced by the occurrence of fetal alcohol syndrome. Also present is 563 
the enzyme 11-ß-hydroxysteroid dehydrogenase 2 (11-ßHSD2) that catalyzes the 564 
conversion of maternal cortisol to its inactive metabolite cortisone. Glucocorticoids are 565 
powerful inhibitors of cell proliferation for most fetal organs, except the heart and 566 
kidney, and the importance of this enzyme for normal development is demonstrated by 567 
the fact that there is a significant correlation between its activity in the human placenta 568 
and birth weight (497, 518). In addition, deletion of the 11-ßHSD2 gene in mice is 569 
associated with fetal growth restriction (261). The amount of cortisol reaching the fetus 570 
will be dependent both on maternal circulating levels and the activity of placental 11-571 
ßHSD2.  Maternal concentrations are elevated in response to stress, which may be 572 
emotional (300), induced by undernutrition (495), or the result of thermal (491) and 573 
other adverse stimuli. Equally, the expression and activity of placental 11-ßHSD2 are 574 
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influenced by a number of factors, including intrauterine growth restriction (221), the 575 
sex of the fetus (132), hypoxia (6), heavy metals such as cadmium that are present in 576 
tobacco smoke (591), and MAPK stress response pathways (498). Resultant exposure to 577 
elevated levels of cortisol may contribute to developmental programming of the fetal 578 
hypothalamic-pituitary-adrenal axis and other organ systems (127, 129, 306).  579 
 580 
D. Sexual dimorphism 581 
The placenta is of the same genotype of the fetus, and there is increasing evidence that 582 
sexual dimorphism in terms of its gene expression may modulate its responses to 583 
environmental stimuli, and so influence the likelihood of fetal developmental 584 
programming. Placentas associated with female fetuses tend to have higher expression 585 
of genes involved in immune regulation, endocrine functions and placental growth (71, 586 
512), whilst those from males have more inflammatory profiles (136). These 587 
observations have lead to the suggestion that females invest more resources in building 588 
the placenta, while males invest more in fetal growth and consequently may have less 589 
placental reserve capacity under adverse conditions (71). The situation is made more 590 
complex by the finding that sex-dependent expression patterns vary amongst the tissue 591 
types comprising the placenta, with differences being observed among purified isolates 592 
of syncytiotrophoblast, cytotrophoblast cells, and arterial and venous endothelial cells 593 
(136).  594 
 595 
Nonetheless, sex-dependent differences in gene expression are likely to underlie the 596 
contrasting placental responses observed following exposure to high-fat/low-fat diets 597 
(202, 356), glucocorticoids (132), or hypoxia (133, 363) in mice. Similarly, lower levels 598 
of mRNAs encoding key enzymes regulating glucocorticoid transfer, including 11ß-HSD2, 599 
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were found in female placentas from women suffering anxiety or depression compared 600 
to male counterparts (381). Hence, female fetuses may be exposed to higher levels of 601 
maternal stress hormones in these cases, but as yet no data on protein levels or enzyme 602 
activity are available to confirm this suggestion.  603 
 604 
At present there are few details of the molecular mechanisms involved, but clearly the 605 
genetic sex plays an important role in determining the placenta’s responses to 606 
environmental insults, and hence how it transduces these to the fetus. The impact of the 607 
sex of the placenta on its various functions is an important area for future research, and 608 
may explain some of the sex-specific aspects of fetal developmental programming (63, 609 
203, 472, 522).  610 
 611 
IV.  PLACENTAL STRUCTURE AND DEVELOPMENT 612 
 613 
While the functions of the placenta are common across all species, its structure is the 614 
most varied of any organ. Although major differences exist among species in terms of 615 
the gross shape of the placenta, the most striking difference is in the degree of invasion 616 
by derivatives of the fetal chorion into the maternal tissues. This varies from no invasion 617 
in the epitheliochorial placenta of ruminants, equids and suids, in which the trophoblast 618 
simply abuts the uterine epithelium, through the partially invasive endotheliochorial 619 
placenta of carnivores, to the fully invasive hemochorial placenta of the human and 620 
rodents where the trophoblast is bathed by maternal blood (583). The reduction in the 621 
number of tissue layers constituting the interhemal membrane as a result of increased 622 
invasion was considered for many years to represent an evolutionary progression. 623 
Molecular phylogenetic data have, however, overturned this view. It is now appreciated 624 
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that the non-invasive epitheliochorial placenta is a derived form that arose by 625 
convergent evolution in different orders, and that the ancestral mammal was most likely 626 
a shrew-like creature with an invasive hemochorial placenta (96, 98, 171, 572). 627 
Epitheliochorial placentation avoids many of the immunological and hemodynamic 628 
problems associated with the invasive forms that underlie complications of human 629 
pregnancy, such as pre-eclampsia, and these may have operated as selective pressures 630 
over the millennia (131, 170, 231).  631 
 632 
Placentas also vary in the degree of interdigitation at the maternal-fetal interface, which 633 
impacts on the surface area for exchange. Patterns vary from the folded type, 634 
characteristic of pigs where there are poorly branched ridge-like folds, through the 635 
more complex villous type, seen in the human and ruminants, to the labyrinthine type of 636 
rodents where intricate networks of maternal and fetal vascular channels permeate   a 637 
block of trophoblast tissue (583). Comparative studies have demonstrated that species 638 
with a labyrinthine placenta have gestation lengths less than half those associated with a 639 
villous or folded placenta, although there are no relationships with birth weight or brain 640 
size (91, 92). Hence, the labyrinthine placenta is capable of delivering nutrients at a 641 
faster rate, which may be traded-off against gestational length in order to prevent 642 
maternal depletion. Short gestations are presumed to have a selective advantage in 643 
environments with marked seasonal changes in food availability.  644 
 645 
 Hence, the form of placentation needs to be considered in the context of the 646 
reproductive strategy of the species concerned and the environment and habitat that it 647 
lives within, for all forms are equally successful in supporting the development of live 648 
offspring. Nonetheless, extreme care needs to be taken when extrapolating data from 649 
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one species to another. Extensive descriptions of different placental types are available 650 
elsewhere (395, 449, 583), and here we restrict our consideration to the human 651 
placenta and that of the two main animal species used in research into developmental 652 
programming, the mouse and the sheep. The mouse is favored because of the ease of 653 
genetic manipulations, which enable, for example, imbalances to be created among 654 
maternal supply, placental size and fetal demands (482). Furthermore, placental 655 
transport capacity can be assayed in vivo (502), and assessed in relation to the maternal 656 
and fetal blood flows monitored using high-resolution ultrasound (399). While 657 
ultrasound permits longitudinal assessment of placental and fetal development, the 658 
small size of the mouse prohibits repeated blood sampling, which represents a 659 
significant limitation for metabolic studies. By contrast, the sheep offers opportunities 660 
for extended experimentation in conscious, ambulant animals through chronic 661 
catheterization of the maternal and fetal circulations. The neonate is also of 662 
approximately the same size as that of the human, and born at a similar degree of 663 
maturation.     664 
 665 
Although research has been performed on other species, including the rat, rabbit, 666 
guinea-pig, pig, horse and non-human primates (94, 520), the data are limited in 667 
comparison. There is no perfect model of human placentation, except for the great apes 668 
in which experimentation is ethically unacceptable. Hence, one has to select the species 669 
most suitable for the question being addressed, giving consideration to factors such as 670 
the number of offspring, the histology of the interhemal membrane, the length of 671 
gestation and the relative mass of the conceptus to that of the mother at term.  672 
 673 
A. The human placenta 674 
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 675 
1. The mature placenta 676 
The mature human placenta is usually a circular or oval disc approximately 22 cm in 677 
diameter (435, 478). The disc is bounded on the fetal surface by the chorionic plate to 678 
which the umbilical cord is attached, and over which the branches and tributaries of the 679 
umbilical vessels radiate. The branching pattern of the chorionic arteries may be 680 
monopodial or dichotomous, and varies depending on the site of insertion of the 681 
umbilical cord. The first two-three generations are always dichotomous, and thereafter 682 
are mostly monopodial if the cord insertion is marginal and dichotomous if it is central 683 
(223). Computational models indicate that energy losses are small in monopodial 684 
branching, and this may be beneficial when perfusing placental territory over a long 685 
distance (224). Conversely, dichotomous branching is more efficient in distributing 686 
blood over large areas near the bifurcation. On the maternal surface is the basal plate 687 
that abuts the decidua, and this is divided into a number of lobes by septa that are 688 
directed towards, but do not reach, the chorionic plate. Hence, the placenta is divided 689 
into a variable number of compartments, and this arrangement may assist in directing 690 
the flow of maternal blood (49).  Lobes are alternatively known as cotyledons, but we 691 
prefer to use the former term to avoid confusion with the ovine placenta. 692 
 693 
Internally, it comprises a series of highly branched villus trees that in total contribute a 694 
surface area for exchange of 12-14 m2 (75). Each tree arises via a stem villus from the 695 
chorionic plate and forms a lobule that is centered over the opening of a maternal spiral 696 
artery through the basal plate, so constituting an individual maternal-fetal exchange unit 697 
(Figure 3A). There may be one or more lobule per lobe. While some villi, the anchoring 698 
villi, extend between the two plates, the majority are free-floating within the cavity of 699 
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the placenta, the intervillous space. The finest branches of the villus tree, the terminal 700 
villi, are highly vascularized with fetal capillaries. Dilations of the capillaries, referred to 701 
as sinusoids, bring the endothelium into close apposition with the overlying 702 
syncytiotrophoblast, which is often locally thinned to form a vasculosyncytial 703 
membrane. Consequently, the diffusion distance between the two circulations may be 704 
reduced to 1-2 µm at these sites, aiding diffusional exchange (Figure 3B).  705 
 706 
The syncytiotrophoblast forms the epithelial covering of the villus tree, and during the 707 
second and third trimesters and is bathed directly with the maternal blood circulating in 708 
the intervillous space (Figure 3B). Hence the human placenta is described as being of the 709 
hemochorial type (49). The syncytiotrophoblast is a terminally differentiated, 710 
multinucleated syncytium.  The apical surface bears numerous microvilli, amplifying the 711 
surface area for receptor-mediated transport by a factor of ~ x7 (302). A wide variety of 712 
receptors have been localized to the microvillous surface, and their activity is responsive 713 
to maternal nutrition (204). Coated pits are observed at the base of the microvilli for 714 
endocytic transport (291, 420).  715 
 716 
The syncytioplasm is dense with organelles, including rough endoplasmic reticulum and 717 
mitochondria, reflecting its high synthetic and metabolic activity. Hence the tissue is 718 
vulnerable to oxidative and endoplasmic reticulum stress, which if not resolved leads to 719 
activation of the unfolded protein response.  These stresses may impact severely on its 720 
endocrine and transport functions, and are associated with growth restriction and other 721 
complications (85, 405, 596). In this respect, comparisons can be drawn between the 722 




 The basal surface of the syncytiotrophoblast contacts either the progenitor unicellular 726 
cytotrophoblast cells, or the trophoblastic basement membrane. In early pregnancy the 727 
cytotrophoblast cells form a complete layer, and so nutrients must either pass through 728 
the cells or through the narrow intercellular clefts. Towards term these cells become 729 
more dispersed, with studies finding that they occupy 44% (290) or up to 90% (392) of 730 
the basement membrane, creating larger gaps for potential paracellular transport.  731 
 732 
The fetal capillaries lie within the stromal core, often closely approximated to the 733 
trophoblastic basement membrane. They form the third layer of the interhemal 734 
membrane, and potentially play an important in regulating maternal-fetal transport  735 
(168, 185). The endothelial cells are of the non-fenestrated type, and are connected by 736 
both tight and adherens junctions (339). The composition of these complexes differs 737 
with gestational age, and with their location in the villus tree. During the first trimester 738 
the tight junctions lack occludin and claudin-1 and -2, suggesting that they are still 739 
plastic and highly permeable (329). This arrangement persists in later pregnancy within 740 
the terminal villi (330), pointing again to the importance of these villi for exchange. 741 
Numerous caveolae are present within the cytoplasm of the endothelial cells, which may 742 
play a role in transcellular endocytic transport. The GLUT3 transporter protein has also 743 
been immunolocalized to the endothelial cells (245), as has the multidrug resistance 744 
protein (540), tocopherol transfer protein (400), and phospholipid transfer protein 745 
(487). However, no data are yet available describing the importance of the different 746 
transcellular and paracellular pathways for the transfer of specific types of nutrients. In 747 
a co-culture model of the interhemal membrane, the endothelial layer was found to offer 748 
greater resistance to the transport of glucose than the trophoblast layer (333). Whilst a 749 
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step forward, these results cannot necessarily be extrapolated to the in vivo condition as 750 
the unicellular HTR8 trophoblast cell line was used, which may not reflect the same 751 
transport properties as the syncytiotrophoblast. Insulin receptors are detectable on the 752 
cell surface from the start of the second trimester onwards (143), and may regulate 753 
villus angiogenesis in metabolic disorders (327). 754 
 755 
2. Development 756 
The human placenta undergoes major transformations in its structure during 757 
pregnancy, and it is important to be aware of these changes when considering the 758 
impact of environmental insults on fetal-placental development.  759 
 760 
Placental development begins with differentiation of the trophoblast lineage at the 761 
morula stage, and there is evidence of plasticity at this early stage. For example, 762 
embryos derived from oocytes retrieved from women with a body mass index greater 763 
than 25 kg/m2 develop faster than those from lean women and have fewer 764 
trophectoderm cells (331). The embryos also display differences in metabolism, with 765 
reduced glucose consumption and altered amino acid usage. Mammalian zygotes do not 766 
form functional gap junctions until around the 8-cell stage, and so the individual cells 767 
behave metabolically in an autonomous fashion (62). It has been speculated that this 768 
lack of cell-cell communication heightens sensitivity to stressors. Thus, the zygote may 769 
be affected by environmental cues transduced through the oviductal secretions during 770 
its passage into the uterus. Equally, it may be influenced by the culture conditions 771 
during assisted reproduction techniques (ART), which can have significant effects on 772 
birth weight (160). The impact of ART on pregnancy outcomes (508), and 773 
cardiovascular health (427), has recently been reviewed, but few data relating to 774 
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placental development are available. A large study of over 500,000 births showed that 775 
placentas arising from ART are heavier than those from natural conceptions (233). The 776 
placental-fetal weight ratio is also increased in ART pregnancies, and this relationship is 777 
independent of the technique employed, the method of delivery and other potential 778 
confounders. However, the mechanism underpinning the effect, and the timing at which 779 
it operates, are still unknown.  780 
 781 
The first morphological evidence of placental development is seen at implantation, 782 
which occurs around day 7 post-fertilization. On attachment to the uterine epithelium 783 
the trophectodermal cells differentiate and fuse to form the syncytiotrophoblast. 784 
Projections from the latter penetrate between the epithelial cells and into the underlying 785 
stroma, so that the zygote is completely embedded within the superficial endometrium 786 
by day 11. The syncytiotrophoblast expands through the proliferation and fusion of 787 
underlying cytotrophoblast cells, and surrounds the entire surface of the original 788 
blastocyst. As it expands, the syncytiotrophoblast erodes into dilated capillaries within 789 
the endometrium, and also the apical parts of the endometrial glands. As a result, 790 
maternal erythrocytes and gland secretions enter into spaces that form within the 791 
syncytiotrophoblastic mantle, the forerunners of the intervillous space (49). 792 
Development of the placenta is precocious, but the factors stimulating and regulating 793 
this rapid development are poorly understood, principally through the difficulty of 794 
obtaining suitable specimens. However, it is now accepted that during the first trimester 795 
the conceptus is supported by histotrophic secretions from the endometrial glands, the 796 
‘uterine milk’ (80, 83).  797 
 798 
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The full composition of the endometrial secretions during pregnancy is not yet known, 799 
but evidence from proteomic analysis during the secretory phase of the non-pregnant 800 
cycle indicate that they likely contain large glycoproteins, including MUC-1, glycodelin-A 801 
and uteroglobin, carbohydrates and lipids (46, 50, 238). These secretions are 802 
phagocytosed by the syncytiotrophoblast (83, 254), and maternal proteins and amino 803 
acids accumulate in the coelomic fluid inside the placental sac (282).  From there, they 804 
may be transported to the embryo via the secondary yolk sac, which floats within the 805 
coelom. The yolk sac is the first of the extraembryonic membranes to be vascularized, 806 
and abnormalities in its development are associated with early pregnancy loss (416). 807 
Recent immunohistochemical studies have located transporter proteins, such as GLUT1, 808 
folate receptor-α, and tocopherol transfer protein, to the outer mesothelial surface (49, 809 
281, 285), but no data are available regarding the yolk sac’s functional capacity for 810 
uptake in vivo. However, deficiency in the transport of retinol and other key signaling 811 
molecules, potentially involving the yolk sac, has been implicated in the causation of 812 
major embryonic defects seen in chromosomally normal spontaneous miscarriages 813 
(440). 814 
 815 
The glandular epithelial cells are also immunopositive during early pregnancy for an 816 
array of powerful mitogens, such as epithelial growth factor (EGF) and vascular 817 
endothelial growth factor (VEGF) (254), and so the secretions may play an important 818 
role in stimulating early development of the placenta. Indeed, evidence from animal 819 
species indicates that the conceptus promotes its own development by signaling to the 820 
glands through placental lactogens and upregulating expression of uterine milk proteins 821 
and growth factors (514). It is suspected, but not yet proven, that the same happens in 822 
the human, possibly augmented by prolactin secreted by the decidual cells (76, 80). The 823 
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fact that the morphology of the glandular epithelial cells changes to a characteristic 824 
hypersecretory type, the Arias-Stella reaction, suggests this may be the case (17).  825 
 826 
Taken together, these data indicate that the endometrium plays a greater role in 827 
stimulating and supporting placental development during early pregnancy than 828 
previously anticipated. The first trimester is a critical period for placental development, 829 
for expression of markers of trophoblast stemness decline rapidly after 12 weeks of 830 
gestation (252), suggesting loss of proliferative potential. Perturbation of endometrial 831 
and, in particular, gland function may therefore have a profound effect on the ultimate 832 
growth of the villus trees and the surface area for exchange. Whether the secretome is 833 
altered in response to maternal nutritional status, obesity or other conditions during 834 
early pregnancy is not known. Further research is necessary to test this hypothesis, and 835 
also to determine whether the endometrial glands may themselves be subjected to 836 
developmental programming. Ultrasound data indicate that the size of the uterus is 837 
reduced in girls born with low birth weight (268), but whether the density or activity of 838 
the glands are also compromised is not known. If so, this could represent a mechanism 839 
mediating intergenerational effects on birth weight.  840 
 841 
Placental metabolism is heavily glycolytic in early pregnancy due to the prevailing low 842 
oxygen concentration (286).  The phylogenetically old polyol pathways are highly active, 843 
avoiding excessive fermentation of glucose to lactate (284). Whether these pathways are 844 
more robust to environmental stressors than oxidative phosphorylation is not known, 845 
but it is notable that the placental ATP/ADP ratio is the same as in later pregnancy, and 846 
that there is no evidence of hypoxic stress in early placental tissues (112).  847 
 848 
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The maternal arterial circulation to the placenta is established towards the end of the 849 
first trimester, and is associated with transformation of the early placenta to its 850 
definitive form. Establishing the circulation requires invasion into, and remodeling of, 851 
the endometrial spiral arteries. This is performed by a sub-population of migratory 852 
trophoblast cells, the extravillous trophoblast, which in normal pregnancies penetrate 853 
the underlying decidua and reach as far as the inner third of the myometrium. 854 
Remodeling of the spiral arteries involves the loss of smooth muscle cells and elastic 855 
tissue from their walls, and their replacement by fibrinoid material (441, 570). As a 856 
result, the vessels loose their vasoreactivity, and their terminal portions dilate as they 857 
approach the basal plate of the placenta. Together, these changes ensure a constant flow 858 
of maternal blood into the placenta at a low velocity and pressure (84). Failure of 859 
trophoblast invasion and arterial remodeling is associated with the ‘Great Obstetrical 860 
Syndromes’, including growth restriction, pre-eclampsia and late spontaneous abortion, 861 
due to impaired maternal perfusion (64). Early in pregnancy the invading trophoblast 862 
cells plug the maternal spiral arteries, preventing flow of maternal blood into the 863 
placenta (264). Towards the end of the first trimester these plugs dislocate, leading to 864 
onset of the maternal arterial placental circulation and the switch from predominantly 865 
histotrophic to hemotrophic nutrition.  866 
 867 
Events at this stage appear to play a major role in determining the final size and shape of 868 
the organ. Villi initially form over the whole of the chorionic sac, but at around 7-8 869 
weeks of gestation those over the superficial pole begin to regress, leaving the smooth 870 
membranes or chorion laeve. This regression is linked with locally high levels of 871 
oxidative stress and apoptosis, for blood flow starts in the periphery of the early 872 
placenta and gradually extends to the central region (283). This pattern reflects the 873 
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extent of extravillous trophoblast invasion and plugging of the maternal spiral arteries 874 
across the placental bed (65). In normal pregnancies, this centripetal regression results 875 
in an approximately discoid placenta with the umbilical cord near the center. However, 876 
we have speculated that if onset of the circulation is more erratic, possibly due to 877 
uneven trophoblast invasion, excessive villous regression may lead to small, abnormally 878 
shaped placentas with eccentrically inserted umbilical cords (77). Unfortunately, this 879 
hypothesis cannot be tested experimentally. However, the site of cord insertion 880 
identified by ultrasound at the end of the first trimester correlates closely with that 881 
observed at delivery, confirming the location is determined early in pregnancy (479, 882 
489). Equally, placentas that are growth restricted at term are smaller than normal at 883 
the end of the first trimester (122, 235), whereas the converse is the case for 884 
macrosomic placentas (490).  885 
 886 
An important question that has not been fully addressed is whether compensatory 887 
lateral growth of the placenta is possible in later pregnancy. There are three aspects of 888 
human placentation that are critical when considering this possibility. First, the 889 
conceptus is completely embedded in the uterine wall, and so it is not just a question of 890 
the placenta expanding over the uterine surface. Any enlargement with respect to the 891 
uterus must be associated with erosion into the maternal tissues. Second, there must be 892 
recruitment of additional spiral arteries to supply any significant increase in territory. 893 
Recruitment is possible during the first trimester when there is an alternative source of 894 
nutrients from the endometrial glands, and a prolific supply of extravillous trophoblast 895 
cells from the cytotrophoblast columns to initially plug the arteries while remodeling 896 
takes place. However, that supply wanes during the second trimester as the columns 897 
become short and sparse, and the villi at the margin of the disc regress. Thus, it is 898 
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probable that the final complement of arteries is essentially fixed at the end of the first 899 
trimester. Third, the uterus obviously expands and remodels as pregnancy advances, 900 
and consequently the relative position of the placental attachment within the uterus 901 
changes with gestational age. This is not achieved through migration or trophotropism 902 
as suggested by early investigators (594), but is principally due to the drawing-out of 903 
the lower uterine segment (257, 404). Hence, whilst in early pregnancy the placenta 904 
grows faster than the uterus and the syncytiotrophoblast mantle expands within the 905 
superficial endometrium (130), it is likely that the placental footprint is established 906 
around the end of the first trimester when formation of the chorion laeve is complete. 907 
Thereafter, it has been suggested that the placenta and uterine wall expand together 908 
(229). Rough estimates based on the density of the spiral arteries in the non-pregnant 909 
uterus and their final disposition in the placental bed at term indicates that this may be 910 
the case. The arteries are initially 2-3 mm apart (41), but at term must be 10-20 mm 911 
apart based on the diameter in the lobules that each supplies (253). Thus, the placental 912 
bed has expanded ~5 fold whereas the diameter of the placenta increases similarly from 913 
5 cm at 11 weeks to 22 cm at term (49). Whether all areas of the uterus expand equally 914 
or whether some areas, such as the fundus, expand preferentially is not known. 915 
However, differential expansion could explain why some placentas are circular and 916 
others elliptical dependent on the implantation site.  Equally, it is not known whether 917 
the density of the spiral arteries is uniform in the uterine wall. If not, then the site of 918 
implantation may affect the ultimate blood supply to the placenta. This linkage provides 919 
a potential mechanism by which the shape of the placenta may be associated with its 920 
functional capacity and the ensuing phenotype of the offspring. 921 
 922 
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If the first trimester sees the establishment of the framework of the placenta, the second 923 
and third trimesters see an increase in its functional capacity, principally owing to the 924 
exponential increase in villous surface area created by the formation of terminal villi 925 
and a reduction in the maternal-fetal diffusion distance (274). It is notable that the 926 
theoretical diffusing capacity for oxygen expressed per kg of fetal weight remains 927 
constant across gestational age (364, 368), suggesting placental development 928 
determines the rate of fetal growth or that the two are closely co-regulated. Formation 929 
of terminal villi is believed to be driven through angiogenesis causing capillary loops to 930 
obtrude from the side of the containing villus (303). Hence, it is likely to be heavily 931 
influenced by the prevailing oxygen tension (312). The vascular network appears to be 932 
particularly plastic during the first trimester due to its low coverage with stabilizing 933 
pericytes at that time (607). Pericyte coverage is also reduced in placentas from 934 
pregnancies at high altitude, which may facilitate vascular adaptations to increase 935 
gaseous exchange, as will be discussed later. 936 
 937 
B. The murine placenta 938 
 939 
1. The mature placenta 940 
The mouse has a single, discoid hemochorial placenta that in terms of its gross 941 
morphology is similar to that of the human. Internally, however, there are significant 942 
differences (210), the most major being that the placenta is divided into two 943 
morphologically and functionally distinct zones; the labyrinth zone that is responsible 944 
primarily for exchange and the junctional zone that serves an endocrine function (Figure 945 
3C). The proportion of these two zones displays considerable plasticity, varying within a 946 
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normal litter depending on the overall placental size and also following dietary and 947 
other manipulations (114, 118, 119). 948 
 949 
The labyrinth zone is closest to the chorionic plate and consists of a dense meshwork of 950 
interconnecting lamellae of trophoblast. Within the lamellae are the fetal capillaries, 951 
whereas between them lie the maternal blood spaces (Figure 3D). The labyrinthine 952 
trophoblast comprises three layers. The outer layer is formed of uninucleate cells that in 953 
the past were referred to as cytotrophoblast cells. However, it is now recognized that 954 
they do not equate in progenitor terms to the cells of the same name in the human 955 
placenta, and their expression of genes encoding placental lactogen suggests they have 956 
an endocrine function (504). They display a large nucleus with evidence of limited 957 
endoreduplication (117), and so are now classified as sinusoidal giant cells (503). 958 
Beneath these cells are two layers of syncytiotrophoblast that are closely approximated 959 
to each other and linked by extensive gap junctions (378, 409). This arrangement is 960 
often referred to as hemotrichorial, although as gestation advances the sinusoidal giant 961 
cells become perforated, allowing maternal blood access to the outer layer of 962 
syncytiotrophoblast (117). The extent to which the two syncytiotrophoblast layers 963 
function as one is also debatable, for the presence of the gap junctions will allow small 964 
molecules to pass easily between them. This is evidenced by the fact that GLUT1 glucose 965 
transporter proteins are only immunolocalized to the apical surface of layer II and the 966 
basal surface of layer III, with none being located at the interface between the two layers 967 
(409). They are also not present on the layer I, the sinusoidal giant cells. Hence, the 968 
arrangement in the mouse may be more analogous to the single layer of trophoblast in 969 
the human than previously anticipated. These proteins, and a variety of amino acid 970 
transporters, appear responsive to maternal nutrition and genetic manipulations of the 971 
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placental to fetal size ratio (14, 204, 566). The trophoblast layers rest on a basement 972 
membrane to which the fetal capillaries are closely apposed on the other side, with no 973 
intervening stromal cells. Unlike the human, the murine syncytiotrophoblast has no 974 
endocrine function (355). 975 
 976 
The junctional zone, in contrast, does not contain fetal blood vessels, and is only 977 
traversed by the maternal spiral artery delivering blood to the labyrinth and venous 978 
channels conveying maternal blood back to the uterine veins. It is composed of two 979 
principal cell types, spongiotrophoblast cells and glycogen cells, and the proportion of 980 
these changes with gestational age. Glycogen cells are sparse before E14.5, but numbers 981 
then expand before declining around E18.5 as they migrate into the decidua (115). As 982 
their name suggests, these cells accumulate large quantities of glycogen that may act as 983 
an energy reserve to be released when growth of the fetus is maximal. 984 
Spongiotrophoblast cells display large quantities of rough endoplasmic reticulum, 985 
suggesting a high secretory output. Many members of the placental lactogen family have 986 
been localized to these cells (355, 507), but the full range of their output is still 987 
unknown. These cells are more vulnerable to stress than the syncytiotrophoblast of the 988 
labyrinth, which may reflect a higher metabolic rate (599).  The venous channels are 989 
lined by other types of polyploid trophoblast giant cells (4, 446, 503). These too have a 990 
potential endocrine function through the release of placental lactogens (504), raising the 991 
possibility that they may relay information to the mother concerning the composition of 992 
her blood following exchange with the fetus. Integration of signals from the sinusoidal 993 
giant cells and the giant cells lining the venous channels could thus provide an indicator 994 
of fetal demand. 995 
 996 
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In addition to the discoid chorioallantoic placenta, an inverted yolk sac placenta is 997 
functional in the mouse from early in pregnancy until term (583) (Figure 3C). The yolk 998 
sac is highly vascularized, and the visceral endodermal layer is exposed to the uterine 999 
lumen and any nutrients secreted by the endometrial glands.  The apical surface of the 1000 
cells resembles in many respects that of the syncytiotrophoblast in the human placenta. 1001 
There is an abundance of microvilli and coated pits, and numerous absorptive droplets 1002 
and vacuoles within the underlying cytoplasm (232). The absorptive function is 1003 
reinforced by the presence of the multifunctional endocytic receptors megalin and 1004 
cubilin that potentially transport a wide variety of vitamins and micronutrients (617). 1005 
The large number of mitochondria and cisternae of rough endoplasmic reticulum 1006 
suggest that the endodermal cells have a high metabolic rate. Experiments in the rat 1007 
have revealed that more than 95% of amino acids transported during the period of 1008 
organogenesis are derived from the uptake and subsequent breakdown of maternal 1009 
proteins by the yolk sac (59, 344).  Perturbation of yolk sac function can thus have 1010 
profound effects on embryo development (455), and so impact on yolk sac function is 1011 
often targeted in screening of potential teratogens. 1012 
 1013 
2. Development 1014 
 1015 
Development of the placenta starts with differentiation of the trophectoderm lineage at 1016 
around E3.5. This process shows considerable plasticity in response to environmental 1017 
cues, such as maternal diet, that influence the ratio and number of trophectoderm and 1018 
inner cell mass cells. A low protein diet during the perimplantation period induces an 1019 
increase in the total number of trophectoderm cells in the blastocyst, suggesting an early 1020 
compensatory reaction (163). However, maintenance on such a diet throughout 1021 
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pregnancy results in reduced placental and pup weights, indicating that growth of the 1022 
conceptus is ultimately constrained by the impoverished nutrient supply (120). 1023 
Implantation commences at E4.5. At this time, the polar trophectoderm cells overlying 1024 
the inner cell mass differentiate into two cell types, extraembryonic ectoderm and the 1025 
ectoplacental cone. The remaining mural trophectoderm cells undergo limited 1026 
proliferation before exiting the cell cycle and transforming into polyploid primary 1027 
trophoblast giant cells (210, 503, 566). These mediate the initial invasion of the 1028 
conceptus at the implantation site, and hence lie at the boundary between the mature 1029 
placental disc and the decidua. They have an endocrine role, expressing several 1030 
members of the prolactin/ placental lactogen gene family, and are also thought to 1031 
secrete angiogenic and vasodilatory factors (503).  1032 
 1033 
It is likely that in rodents embryogenesis and early placental development take place in 1034 
a low oxygen environment, as in the human, for at E6 the antimesometrial decidual cells 1035 
form an avascular zone around the conceptus, separating it from the maternal blood 1036 
(430). Nutrition at this time is histotrophic, absorbed principally through the visceral 1037 
yolk sac. The yolk sac grows at a prolific rate and soon encapsulates the conceptus 1038 
except for the region of the ectoplacental cone. Initially, the yolk sac comprises an outer 1039 
avascular parietal layer formed from the primary trophoblast giant cells and endoderm, 1040 
and an inner vascularized visceral layer. Nutrients must diffuse through the parietal 1041 
layer to be absorbed by the visceral layer. Later in pregnancy the parietal layer breaks 1042 
down with migration of the giant cells, exposing the visceral layer directly to the uterine 1043 
epithelium and forming an ‘inverted’ yolk sac (583).  1044 
 1045 
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The chorioallantoic placenta develops from both the ectoplacental cone and the 1046 
extraembryonic ectoderm. The former gives rise to the spongiotrophoblast and glycogen 1047 
cells of the junctional zone, and a second wave of giant cells (503). These secondary 1048 
trophoblast giant cells invade along the lumens of the spiral arteries, and are therefore 1049 
analogous to the endovascular extravillous trophoblast of the human placenta. The 1050 
extraembryonic ectoderm gives rise to the trophoblast forming the labyrinth. At E8.5 the 1051 
allantois attaches to the expanding extraembryonic ectoderm, bringing in mesoderm 1052 
from which the fetal vasculature differentiates. Allantoic attachment stimulates folding 1053 
within the ectoderm layer, initiating the formation of the trabecular network of 1054 
trophoblast and maternal blood spaces. The genes and transcriptional networks 1055 
regulating placental development in the mouse have recently been extensively reviewed 1056 
(511, 566).  1057 
 1058 
The fetus becomes dependent on the chorioallantoic placenta from E10.5, and hence 1059 
gene mutations that severely compromise placental function cause embryonic lethality 1060 
at this time. The placenta undergoes rapid growth, with weight reaching a maximum 1061 
around E16.5 and plateauing, or even declining, thereafter (116). By contrast, peak fetal 1062 
growth is seen around E18.5. As in the human, it appears that trophoblast proliferative 1063 
potential is limited to early pregnancy, for progenitor cells positive for EpCAM, a marker 1064 
of stemness, are not detectable within the labyrinth after E14.5 (538). However, 1065 
stereological analyses reveal that the labyrinth continues to expand in volume until 1066 
E16.5 and more slowly thereafter (116). This enlargement is associated principally with 1067 
an increase in the volume of the maternal blood spaces and fetal capillaries. While the 1068 
surface area of the maternal blood spaces reaches a maximum at E16.5, that of the fetal 1069 
capillaries continues to increase until term, allowing for the possibility of adaptations 1070 
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during late pregnancy.  Continuing fetal placental angiogenesis is reflected in a 1071 
progressive reduction in the thickness of the interhemal membrane, and consequently 1072 
the theoretical diffusing capacity of the placenta rises until term (116).  By the end of 1073 
pregnancy, the conductance for oxygen in the murine placenta is approximately the 1074 
same as in the mature human placenta (364). 1075 
 1076 
By contrast, the volume of the junctional zone peaks at ~E16.5 due to an increase in 1077 
both the number and mean cell volume of the spongiotrophoblast and glycogen cells, 1078 
and then declines (115). The decline in volume towards term reflects the migration of 1079 
the glycogen cells into the decidua, but this cannot account for the whole change and 1080 
there may be additional cell loss through apoptosis. 1081 
 1082 
C. The ovine placenta  1083 
 1084 
1. The mature placenta 1085 
Morphologically, the placenta of the sheep is very different from those of the human and 1086 
the mouse, although there are many functional similarities. The ovine placenta is of the 1087 
cotyledonary type, comprising approximately 70 placentomes of 0.5 – 4.0 cm diameter 1088 
in a singleton pregnancy (516). A placentome is formed when villous outgrowth creates 1089 
a fetal cotyledon opposite a pre-existing non-glandular specialization, a caruncle, in the 1090 
wall of the uterus (Figure 3E). Thus, placentomes are only formed at predetermined 1091 
sites, and there is no villus regression as in the human. The fetal villi interdigitate with 1092 
crypts in the maternal caruncle, and the complexity of branching increases with 1093 
gestational age. Each cotyledon functions as an independent maternal-fetal exchange 1094 
unit, and is therefore analogous to a single lobule of the human placenta.  1095 
 45 
 1096 
Histologically, the maternal-fetal interface is also different. The trophoblast covering the 1097 
fetal villi remains unicellular, and the cells are linked at their apices by tight junctions to 1098 
form a columnar epithelium.  There is no invasion by the fetal tissues comparable to that 1099 
seen in the human and murine placentas, and the interface is formed by a microvillar 1100 
interdigitation with the maternal tissues (Figure 3F). The exception is the migration of 1101 
binucleate cells that arise in the trophoblast layer just prior to implantation, and form 1102 
15-20% of the layer throughout gestation (583). These cells migrate across the interface 1103 
and fuse with the uterine epithelial cells to form localized plaques of maternal-fetal 1104 
syncytium that are interspersed amongst the otherwise unicellular uterine epithelium 1105 
(583). The placental interface in the sheep is therefore referred to as 1106 
synepitheliochorial. The binucleate cells contain large numbers of dense granules that 1107 
are immunoreactive for ovine placental lactogen (581). Their migration appears to be a 1108 
way of delivering this hormone, and possibly other effectors, into the maternal 1109 
circulation, where it plays an important role in early pregnancy by stimulating activity of 1110 
the endometrial glands and the secretion of uterine milk (415).  1111 
 1112 
Dense capillary plexuses are present within both the fetal villi and the maternal crypts. 1113 
The fetal capillaries display sinusoidal dilations, as in the human, which may serve to 1114 
reduce the vascular resistance (234). Nutrients and respiratory gases thus have to pass 1115 
through six tissue layers; the maternal endothelium, maternal stromal tissue, the 1116 
maternal-fetal syncytium, the trophectoderm, fetal stromal tissue and the fetal 1117 
endothelium (Figure 3F). Diffusional exchange is facilitated by the invagination of the 1118 
fetal capillaries into the trophectoderm, which along with the apposing syncytium is 1119 
locally thinned, forming the equivalents of vasculo-syncytial membranes in the human 1120 
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placenta. Exchange of glucose is aided by the presence of GLUT1 and GLUT3 that are 1121 
expressed on different membranes (95, 582). Amino acid transporters have been 1122 
characterized functionally in vivo, although not localized to individual cell layers (44). 1123 
 1124 
In addition, there are two specialized accessory structures that contribute to nutrient 1125 
transfer. Firstly, in the center of each placentome is a hemophagous zone where 1126 
maternal blood is released by limited degradation of the uterine tissues, sequestered 1127 
and then phagocytosed by the trophoblast cells (79). This is considered to be the 1128 
principal pathway for the maternal-fetal transfer of iron. Since there is no evidence of 1129 
circulation of maternal blood through these regions, they cannot be considered 1130 
analogous to a hemochorial placenta. Secondly, openings of uterine glands are found 1131 
clustered in the uterine wall between the placentomes. The trophoblast cells opposite 1132 
are transformed from cuboidal to columnar, and form small elevations known as areolae 1133 
(Figure 3E). Histotrophic secretions from the glands are endocytosed by the trophoblast, 1134 
representing a pathway for the transfer of large proteins. The areolae reach their 1135 
maximum diameter of ~3 mm in the last third of pregnancy although this decreases 1136 
considerably towards term, most likely due to diminishing activity of the glands (578). 1137 
 1138 
2. Development 1139 
As in the human and mouse, maternal diet during the periconceptional period can 1140 
influence both the number of cells in the blastocyst and also the ratio between the cell 1141 
lineages (299). This sensitivity is further evidenced by the impact that embryo transfer 1142 
or assisted reproductive technologies has on subsequent ovine placental development, 1143 
particularly its vascularization and expression of sex steroid receptors (462). 1144 
Implantation is relatively later in the sheep than in the other species, and there is no 1145 
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invasion of the maternal tissues. Consequently, the conceptus remains within the 1146 
uterine lumen throughout the whole of pregnancy. After entering the uterus the 1147 
blastocyst elongates rapidly, a response driven principally by the endometrial 1148 
secretions.  Their importance has been demonstrated by endocrine ablation of gland 1149 
development in newborn lambs (227, 514, 515). Complete ablation results in a cessation 1150 
of growth of the conceptus and loss of the pregnancy in the adult animal, whereas 1151 
partial ablation leads to a small, non-expanded conceptus that fails to attach. Following 1152 
expansion, trophoblastic papillae project into the mouths of the endometrial glands and 1153 
immobilize the conceptus. Villous development starts opposite caruncles around days 1154 
24-26 post-fertilization, which corresponds to the timing of allantoic attachment with 1155 
the chorion, as in the mouse (583). The number of cotyledons is fixed by about 5-6 1156 
weeks of pregnancy and does not increase thereafter. Each cotyledon does expand, 1157 
however, reaching maximum weight at 80-90 days after which there is a decline due to 1158 
loss of water and a reduction in the mesenchymal component of the fetal villi (516). 1159 
Together, the caruncular and cotyledonary portions at each implantation site form 70-1160 
100 placentomes, which have been be classified into 4 different types on the basis of 1161 
their gross morphology (545).  The frequency distribution of the different placentome 1162 
types changes with gestational age and sub-optimal environmental conditions, although 1163 
functional significance of the different types and the mechanisms governing the shape 1164 
changes remain unclear (198). 1165 
 1166 
The surface area of the maternal-fetal interface increases in line with placental weight 1167 
during gestation due to the increasing length and branching of the fetal villi. In addition, 1168 
towards term the distal parts of the villi are thrown into folds that presumably generate 1169 
further surface area for exchange, despite the decreasing placental weight (234). 1170 
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Vascularization of the villi appears to increase continuously throughout pregnancy, 1171 
although it occurs at twice the rate on the fetal as on the maternal side (54). On the 1172 
maternal side the changes are predominantly in capillary diameter rather than number, 1173 
whereas on the fetal side there is more branching angiogenesis. Consequently, total fetal 1174 
capillary surface area increases, favoring exchange, although mean diameter is reduced, 1175 
as in the mouse (54, 116). These contrasting patterns reflect different expression of 1176 
angiogenic factors in the maternal and fetal tissues (54). The increase in vascularization 1177 
is matched by exponential rises in uterine and umbilical blood flows throughout 1178 
pregnancy, which are of critical importance for fetal growth (461).  1179 
 1180 
V.  EPIDEMIOLOGICAL ASSOCIATIONS BETWEEN PLACENTAL PHENOTYPE AND 1181 
ADULT DISEASE 1182 
 1183 
Low birth weight usually implies inadequate placental function, either as a primary or 1184 
secondary cause. In recent years, an increasing number of relationships have been 1185 
discovered between placental phenotypic features, such as its weight, length and width, 1186 
and diseases in later life (Table 1).  While correlation does not necessarily equate with 1187 
causation, one possibility is that these gross morphological features are linked 1188 
biologically to the functional capacity of the placenta. Alternatively, it may be that these 1189 
features impose mechanical or other constraints on the developing embryo/fetus.  Thus, 1190 
there is accumulating evidence that the vascular arrangement of the early embryo plays 1191 
an important mechanical role in regulating gene expression in the developing heart.  1192 
Cells in the common ventricle and the outflow tract of the embryonic heart are sensitive 1193 
to wall and shear forces (342, 442), and increases in these forces can lead to heart 1194 
defects (135, 260, 379).  The heart of the human embryo begins beating around day 21 1195 
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post-conception. From then on, it is subject to the pulsatile pressures and flows 1196 
generated by its own pumping action.  At 6-8 weeks the heart has become 4 chambered, 1197 
and the vitelline and allantoic circulations are increasingly perfused (Figure 4). These 1198 
vascular beds offer mechanical resistance to blood flow, and there is increasing evidence 1199 
that their inadequate growth promotes mechanical signals in the heart that result in 1200 
structural defects (218, 260, 341, 379).  We suspect that changes in the yolk sac and/or 1201 
early placental vascular architecture underlie a broad spectrum of cardiovascular 1202 
disorders, including a propensity for heart failure, but confirmatory data are not yet 1203 
available.   1204 
 1205 
A. Placental Efficiency 1206 
While fetal weight generally correlates with placental weight, the efficiency of the 1207 
placenta, defined as the amount of fetal body mass accumulated per gram of placenta, is 1208 
a key indicator of the offspring’s resilience and susceptibility to chronic disease in later 1209 
life (576). This index is a simple one to calculate in epidemiological studies, and 1210 
encapsulates many different factors, such as placental exchange surface area, 1211 
transporter density and activity, and blood flow rates, which would require more 1212 
detailed individual stereological, molecular or physiological analyses. However, while it 1213 
provides an overview of placental function, changes in the index provide no insight into 1214 
whether specific activities have been stimulated or compromised, and, if so, the 1215 
mechanisms involved. The physiological and endocrine regulation of placental efficiency 1216 
has recently been reviewed (196).  Efficiency, as estimated by this index, varies 1217 
dramatically among species. The index is not related to the histological type of the 1218 
placenta, but to the relative geometries of the maternal and fetal blood flows (137), 1219 
emphasizing the importance of flow-limited transport. The human placenta is notably 1220 
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one of the least efficient on this basis, suggesting that other evolutionary selective 1221 
pressures have been more important.  1222 
 1223 
In the human, large placentas tend to less efficient than smaller ones (384, 480), 1224 
suggesting adaptations, such as changes in transporter expression, have been successful 1225 
in the latter.  The risk of cardiovascular disease in adult men in relation to the birth 1226 
weight to placental weight ratio does not follow a linear fashion as one might expect, but 1227 
rather a “U” shaped pattern with heart-related death rates being lowest when placental 1228 
weight is ~19% of birth weight (Figure 5) (25, 217, 361). The explanation for this 1229 
relationship is not intuitively obvious, for it might be assumed that the more weight 1230 
achieved per gram of placenta, the better the fetal outcome. However, it is possible that 1231 
very small placentas are symptomatic of a severely compromised and constraining 1232 
maternal-fetal supply line, and have a limited functional capacity (477). Large placentas 1233 
on the other hand may imply that compensatory growth was stimulated by inadequate 1234 
access to nutrients at key phases of development.  This phenomenon is well known to 1235 
farmers, who graze ewes on poor pasture after mating to stimulate placental growth, 1236 
before placing them on good pasture during mid- to late-pregnancy. In doing so, they 1237 
obtain larger lambs than ewes grazing on good pasture throughout (373). In the non-1238 
human primate, a reduction in placental mass can be compensated by expansion of the 1239 
remaining placenta.  However, this plasticity is lost as term approaches (466).   When, 1240 
and how, the human placenta is able to adapt to different nutritional conditions is poorly 1241 
understood.  1242 
 1243 
There is considerable variation in placental efficiency across the birth weight range, as 1244 
demonstrated by the relationship between 17,000 birth weight-placental weight pairs 1245 
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from deliveries in Saudi Arabia (11) (Figure 6). If the data are divided into quadrants 1246 
based on the approximate median birth weight and placental weight then in the upper 1247 
left quadrant, heavy babies were nourished by relatively light placentas, whereas in the 1248 
lower right quadrant babies were light even though their placentas were at the heavier 1249 
end of the scale. On the basis of the “U” shaped pattern described above, one might 1250 
speculate that people born in these quadrants may have higher than average risks for 1251 
chronic conditions in later life  (217).  It would be interesting to know whether these 1252 
extreme quadrants have different sex ratios. On average, boys have heavier birth 1253 
weights per gram of placenta (173), and thus would be expected to be more numerous 1254 
in the upper left quadrant.  By contrast, girls tend to make larger placentas for any given 1255 
birth weight, and so may be more likely to populate the lower right quadrant. This 1256 
remains to be tested.  1257 
 1258 
There is increasing evidence that placental efficiency changes over time in any given 1259 
population, and is likely to be influenced by the nutritional environment.  The data from 1260 
Saudi Arabia mentioned above showed that placental efficiency decreased significantly 1261 
over a decade (11). This change was due solely to an increase in placental weight, which 1262 
rose by more than 100g without a concomitant increase in birth weight. Studies in 1263 
Mysore, India, suggest that maternal head circumference in conjunction with maternal 1264 
fat mass predict placental efficiency (579).  The former is related to the mother’s early 1265 
life nutrition, whereas the latter reflects levels of nutrition during adulthood.  This 1266 
finding suggests that the nutritional conditions across the life of a woman are highly 1267 
influential in the establishment and growth of the placenta, and thus impact the lifelong 1268 
health risks of her offspring. However, it has not been determined whether the optimal 1269 
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efficiency associated with low cardiovascular death rates originally found in the UK 1270 
population (Figure 5) applies to populations in Saudi Arabia and elsewhere.  1271 
 1272 
B. Placental shape and its influence on fetal development. 1273 
The human placenta is generally described as discoid, but in large populations it has 1274 
often been found on average to be slightly elliptical (435).  Among ~6,000 placentas in 1275 
the Helsinki Birth Cohort, the placentas were some 2.6 cm longer in one direction than 1276 
in the other (172).  Because the Helsinki data allow so many comparisons with a variety 1277 
of diseases, it has become clear that the degree to which a placenta deviates from being 1278 
perfectly round has a predictive value for specific diseases. Here, we define “length” of 1279 
the delivered placenta as the longest dimension, and “width” as the longest distance 1280 
measured perpendicular to the first.  Assuming an elliptical surface, the average 1281 
thickness can be estimated by the weight of the delivered placenta divided by the 1282 
estimated surface area, the length × width × π/4 (172). A frequent finding is that 1283 
although length and width correlate in any sample of placentas, the two measurements 1284 
often have independent associations with fetal growth parameters as well as with 1285 
postnatal disease. For example, simultaneous regression revealed that increasing 1286 
ponderal index and the circumferences of the head, chest, abdomen and thigh among 1287 
newborns are all highly associated with placental width; however, none are related to 1288 
placental length (12). For each cm increase in placental width, birth weight increased by 1289 
125 g (95% confidence interval 88 to 162, p < 0.001) but only by 20 g for each cm 1290 
increase in placental length (-13 to 53, p= 0.2). Mothers below the median height 1291 
(157cm) had the strongest associations between placental width and neonatal body size.    1292 
 1293 
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The biological links among placental shape, size and function have not been defined.  It 1294 
has been proposed that different regions of the placenta have specific roles in nutrient 1295 
transport, and that the placenta has a polarity related to the rostral-caudal axis of the 1296 
early embryo (12, 298).  However, there are no experimental data to substantiate this 1297 
speculation. A more likely explanation is that placental shape is a powerful proxy 1298 
indicator of processes in placentation that are related to its transport and physiological 1299 
functions.  As described in section IV.A.2, placental shape may reflect the site of 1300 
implantation, or events taking place during the transition of the early placenta to its 1301 
definitive form. For the former, implantation at different sites within the uterus, such as 1302 
on the anterior or lateral walls, close to the cervix or in the fundus, may lead to variable 1303 
shapes depending on whether the uterus expands symmetrically during later pregnancy 1304 
or preferentially in certain dimensions. If uterine vascularity is different at these 1305 
implantations sites, in terms of the density of the arcuate and spiral arteries, then 1306 
placental blood flows, and hence functional capacity, will correlate with placental shape. 1307 
For the latter, excessive villous regression at the time of onset of the maternal 1308 
circulation may be indicative of deficient extravillous trophoblast invasion (77), which 1309 
may mean that the remaining spiral arteries are not fully remodeled, compromising 1310 
placental blood flow. 1311 
 1312 
The lack of certainty over the role of placental shape in driving biological function is 1313 
based on a paucity of basic data detailing how the placenta actually grows, and how 1314 
shape is determined. Placental growth patterns measured over intervals across 1315 
gestation are needed, and this may be possible with the advent of high-resolution 1316 
ultrasound from which volumetric and shape data can be obtained. Once the 1317 
mechanisms are known, it should be possible to determine how maternal diet, body type 1318 
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and lifestyle alter the placenta over its lifespan. We also need more detailed information 1319 
on the regional distribution of spiral arteries, and how the uterus and placenta co-1320 
expand during pregnancy. The visualization of placental oxygenation, metabolism and 1321 
nutrient transport in real-time would further illuminate the relationships between 1322 
shape and placental function, and may become possible through magnetic resonance 1323 
imaging techniques. At present, data show that elliptical placentas tend to be less 1324 
efficient than circular ones (590), but more research is needed to understand the 1325 
underlying biology.   1326 
 1327 
C. Placental inflammation 1328 
A number of maternal conditions, both infectious and non-infectious, have been linked 1329 
to placental inflammation (102, 453). Elevated levels of placental inflammation have 1330 
been associated independently with slower post-natal growth in pre-term infants, and 1331 
so may have long-lasting effects for adult health (377). 1332 
 1333 
It is becoming increasing clear that standard definitions of inflammation do not fit the 1334 
findings in the placenta in non-infectious cases, such as obesity and diabetes, for it is 1335 
possible for inflammatory pathways to be activated without the classic infiltration of 1336 
granulocytes (418).  Recently, new definitions have been applied to chronic 1337 
inflammatory states in adult tissues (87).  The basis for this reappraisal is the 1338 
recognition that the same signaling cascades that are activated in classical inflammation 1339 
in response to pathogens, including activator protein 1 (AP1), NF-κ B and interferon 1340 
regulatory factors (IRFs), can be stimulated by cytokines arising from a variety of 1341 
metabolically active tissues, such as adipose tissue, muscle and liver, and their resident 1342 
immune cells in response to excess nutrients (228, 567). The outcome has been termed 1343 
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metaflammation, or ‘cold, smoldering inflammation’ as it is characterized by its 1344 
chronicity. Since the tissues remain in an anabolic state, there is the capacity for tissue 1345 
remodeling and gradual metabolic deterioration over time (87).  1346 
 1347 
It is likely that the stressors known to lead to fetal programming, including insufficient 1348 
or excess nutrition, social stress and hypoxia, can lead to metaflammation in the 1349 
placenta. Indeed, the same inflammatory pathways can be activated through the 1350 
signaling cascades of the unfolded protein response (UPR) (228, 609), as will be 1351 
discussed later.  These cascades are activated in placentas from cases of growth 1352 
restriction and early-onset pre-eclampsia (595, 596), but no data are yet available for 1353 
pregnancies complicated by maternal obesity or other metabolic disorders. A sterile 1354 
inflammatory state can also arise through senescence, when cells adopt the senescent-1355 
associated secretory phenotype (SASP) and release pro-inflammatory cytokines and 1356 
proteases (425). Senescence has only recently been considered a potential feature of the 1357 
syncytiotrophoblast in human placenta (220). While it may be part of the normal aging 1358 
process, the fact that it can be induced by chronic stress, including oxidative and 1359 
endoplasmic reticulum stress, suggests it may be more prevalent in complicated 1360 
pregnancies. 1361 
 1362 
Although the intermediate molecular mechanisms remain uncertain, we speculate that 1363 
metaflammation is present in the human placenta in pregnancies complicated by 1364 
malperfusion or maternal metabolic disorders (Figure 7). It may mediate programming 1365 
of the fetus by either adversely affecting placental function, or by causing the release of 1366 
pro-inflammatory cytokines into the fetal circulation.  1367 
 1368 
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D.  Specific examples linking placental phenotype to chronic disease 1369 
Here, we explore associations between placental phenotypes and adult chronic diseases 1370 
resulting from epidemiological studies. In each case the findings have been corrected for 1371 
known confounders. Epidemiological studies are unable to separate cause from effect, 1372 
but these associations provide the opportunity to investigate the underlying biology. 1373 
 1374 
1.  Hypertension 1375 
Most of the epidemiological data related to hypertension have arisen from studies of 1376 
large cohorts followed from birth to the present day. One such is the Helsinki Birth 1377 
Cohort that comprises 13,345 men and women born during 1934-1944. Among the 644 1378 
hypertensive subjects, treatment for hypertension was associated with low placental 1379 
weight and surface area (39). Birth weight is linked to maternal body size and 1380 
composition, as well as to growth of the placenta. When taking maternal characteristics 1381 
into consideration, the associations were strongest among mothers whose stature was 1382 
below average height (160cm), or who were of low socioeconomic status (Figure 8). 1383 
This suggests an interaction between the role played by the placenta and the nutritional 1384 
state of the mother during her early development.  Among these shorter women, the 1385 
prevalence of hypertension fell from 38% if the placental area was 200 cm2 or less, to 1386 
21% if the area exceeded 320 cm2 (p=0.0007). Poor maternal nutrition may exaggerate 1387 
the adverse effects of small placental size on fetal development, possibly by restricting 1388 
compensatory mechanisms.   1389 
 1390 
Among men who were exposed in utero to the starvation effects of the post-war famine 1391 
in Holland, a reduced width of the placenta was associated with hypertension (471).  1392 
The surface area of the placenta also predicted hypertension with an odds ratio of 1.34 1393 
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(95% CI 0.99 to 1.80) for an increase in surface area of 40 cm2.  However, hypertension 1394 
was predicted by a short placental width and a more oval shape in men who were born 1395 
after the war (471, 541). 1396 
 1397 
There are also effects of placental development on blood pressure in children. A study of 1398 
placentas of children in the longitudinal Alspac study of 13,971 births in Bristol UK, 1399 
showed the number of lobes on the maternal surface was related to the blood pressure 1400 
of the children at age 9 years (24).  Increasing lobe number (range 4 to 40) was 1401 
associated with higher blood pressures in both boys and girls. The larger the surface 1402 
area of the placenta, the more lobes it contained and the heavier the birth weight of the 1403 
offspring.  However, among boys, the number of lobes was directly associated with 1404 
higher systolic and diastolic pressure, but not with an increased pulse pressure. In that 1405 
group, diastolic pressure rose by 2.2 mmHg (95% CI 0.6 to 3.7, p =0.007) for every 10 1406 
additional lobes. A greater number of lobes was associated with higher systolic pressure 1407 
and pulse pressure, but not with higher diastolic pressure, in girls. Pulse pressure rose 1408 
by 2.7 mmHg (1.1 to 4.3, p<0.001) for every 10 additional lobes. Adjustment for 1409 
placental surface area, a powerful determinant of hypertension in adult men, did not 1410 
change the relationships.  Although we do not understand how lobation of the human 1411 
placenta arises developmentally (49), these data are fascinating for two reasons. Firstly, 1412 
since septae are first observed projecting from the basal plate as early as six weeks of 1413 
gestation, they may represent an informative proxy marker of early events in placental 1414 
development that are of physiological consequence. Secondly, they complicate the role 1415 
of placental area as a predictor of adult hypertension, for the number of lobes is the 1416 
more powerful index.  1417 
 1418 
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2. Heart Failure  1419 
Returning to the Helsinki Birth Cohort, 187 patients were taking medications for chronic 1420 
heart failure.  Their disease was associated with a small surface area of the delivered 1421 
placenta, and the odds ratio for chronic heart failure was 1.7 (1.1–2.5) in men and 1422 
women born with a placental area <225 cm2 compared those with an area >295 cm2 1423 
(27). There was no relationship with placental weight. As with hypertension, the 1424 
relationships were strongest among women of below median stature (Table 2), 1425 
suggesting a link with the mother’s own nutritional state during her fetal and childhood 1426 
development.  1427 
 1428 
In a separate study of adult men, concentric enlargement of the left ventricle, a known 1429 
predictor of coronary heart disease, was found to be associated with low weight at 1 1430 
year (548). It was speculated that this was due to altered hemodynamics during the fetal 1431 
period, or a persisting elevation of growth factors. Taken together, these data suggest 1432 
that chronic heart failure in adult life may be initiated by impaired placental growth, 1433 
which subsequently adversely affects cardiac development.  In addition, people born 1434 
with a vulnerable heart are more likely to develop chronic heart failure if they become 1435 
insulin resistant (27). 1436 
 1437 
3. Coronary Heart Disease 1438 
Numerous studies have shown a relationship between cardiovascular disease and 1439 
restricted growth before birth (5, 182, 428). However, the finding that the placenta is a 1440 
more powerful driver of coronary heart disease in men (182) than in women (175) is a 1441 
recent discovery. A study of 6975 men in the Helsinki Birth Cohort found that three 1442 
different placental phenotypes were associated with disease of the coronary arteries 1443 
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(175). In the first, an increasing difference between the length and width of the placenta 1444 
predicted the disease in the offspring of primiparous mothers who were of below 1445 
median height. The hazard ratio for each cm in difference between length and width was 1446 
1.14 (95% C.I. 1.08–1.21, P = 0.0001). The second placental phenotype was a small 1447 
surface area of the delivered placenta.  In tall mothers whose body mass index was 1448 
above the median, a 40 cm2 decrease in surface area was associated with a hazard ratio 1449 
of 1.25 (1.10–1.42, P =0.0007).  The third phenotype was found also in tall mothers, but 1450 
only those whose body mass index was below the median.  In these mothers, the hazard 1451 
ratio was 1.07 (1.02–1.13, P = 0.01) per 1% increase in the placental weight/birth 1452 
weight ratio.  These data suggest an interaction between a mother’s body size and 1453 
composition and placentation that leads to a particular capacity for nutrient exchange 1454 
and efficiency.  Coronary heart disease was associated with a low ponderal index (birth 1455 
weight/length3) in all groups, suggesting that the fetuses were all undernourished 1456 
because of poor placental growth.  1457 
 1458 
Whereas placental size usually correlates with maternal body size, coronary heart 1459 
disease in men was associated with a small placenta in tall mothers.  This suggests poor 1460 
placentation and poor placental growth throughout pregnancy.  It was placental 1461 
inefficiency that predicted the disease in the third group.  In this group, thin tall women 1462 
had large placentas in proportion to the size of the baby at term.  In these women, 1463 
placenta growth may have been stimulated by poor maternal nutrition at mid-gestation.     1464 
 1465 
4. Sudden Cardiac Death 1466 
Because it is not possible to study the living hearts of people who have died suddenly 1467 
from cardiac causes, it has been very difficult to pinpoint the electrical properties of the 1468 
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myocardium in hearts whose contractility suddenly becomes inadequate to sustain life.  1469 
Nonetheless, aberrant functioning of the autonomic nervous system is considered the 1470 
most common explanation for sudden cardiac death (201).  While it is known that 1471 
sympathetic tone may be exaggerated in people who had low birth weight, the links 1472 
among maternal, placental, and fetal growth have only recently been explored through 1473 
the Helsinki Birth Cohort. Sudden unexplained cardiac death outside hospital was 1474 
associated with a thin placenta, and for each gram/cm2 decrease in thickness the hazard 1475 
ratio was 1.47 (95% C.I. 1.11–1.93, P=0.006) (30).  A high placental/birth weight ratio 1476 
also predicted sudden death among women, but not men. The determinants of placental 1477 
thickness are not fully understood, but if the theory that abnormal autonomic function 1478 
underlies sudden death holds then one might suspect a relationship between the 1479 
nutritional function of a thin placenta and development of the autonomic nervous 1480 
system during fetal life.  1481 
  1482 
5. Lung and Colorectal Cancers 1483 
Susceptibility to developing cancer on exposure to carcinogens, such as those in tobacco 1484 
smoke, differs among individuals.  Through a combination of the Helsinki Birth Cohort 1485 
with an older cohort born in 1924–1933, the smoking history was known for 6,822 men 1486 
and women, of which 385 developed lung cancer by 2010. The cases were characterized 1487 
by having a short mother and a high ponderal index (weight/length3) at birth, and the 1488 
delivered placenta had either a small or a large surface area in three separate 1489 
phenotypes (38).   It was suggested that in each phenotype, low amino acid transport 1490 
but normal glucose transfer was reflected in a newborn that was short in relation to its 1491 
weight. These data indicate that both large and small placentas can limit the flow of 1492 
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nutrients, and that poor placentation occurs more often in women who are short in 1493 
stature. 1494 
 1495 
In the combined Helsinki cohorts, 275 had colorectal cancer (36).  The risk for acquiring 1496 
the disease increased as the placental surface became longer and more oval. Among 1497 
people in whom the difference between the length and breadth of the surface exceeded 1498 
6 cm, the hazard ratio was 2.3 (95% CI 1.2–4.7) compared with those in whom there 1499 
was no difference. Colorectal cancer was unrelated to other placental measurements or 1500 
to body size at birth.  Thus, colorectal cancer had a graded association with placental 1501 
elipticity.   1502 
 1503 
VI. OXYGEN SENSING BY PLACENTAL CELLS 1504 
Placental cells, and in particular the trophoblast, are metabolically highly active due to 1505 
their multiple functions. Thus, it has been estimated that the placenta accounts for 1506 
~40% of the oxygen consumption of the fetal-placental unit, and of that ~33% is utilized 1507 
in active transport and ~33% in protein synthesis (97). It is therefore to be expected 1508 
that placental cells are sensitive to oxygen availability. There are a number of potential 1509 
pathways by which cells may sense the prevailing oxygen concentration (Figure 9), and 1510 
there is evidence of considerable interplay between them (180, 324, 562). Given that 1511 
oxygen is central to cell metabolism some of these pathways also overlap with those 1512 
sensing energy levels and nutrient supply. Here, the respective pathways will be 1513 
considered according to their principal function. Equally, activation of the two sets of 1514 
pathways causes, to a large extent, a common outcome, for under conditions of hypoxia 1515 
or nutrient deprivation there is a need to conserve energy reserves by stimulating 1516 
glycolysis and suppressing non-essential protein synthesis. Responses to hypoxia 1517 
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generally begin when the oxygen concentration falls below a cell’s critical threshold that 1518 
switches aerobic oxygen-regulated metabolism to anaerobic oxygen-conforming 1519 
metabolism (225). That threshold is likely to be different for different cell types within 1520 
the placenta dependent on their metabolic activity and other factors, but no data are 1521 
available as to what the precise values might be. For most primary or transformed 1522 
mammalian cells it is within the range of ~0.15 - 1.5% oxygen (225). Equally, although it 1523 
is commonly asserted that the placenta is hypoxic in pathological states, such as pre-1524 
eclampsia, no measurements have been made in vivo to confirm whether or not this is 1525 
the case.  These claims must therefore be treated with caution. 1526 
 1527 
There are a variety of signaling mechanisms that are activated in response to hypoxia, as 1528 
follows. 1529 
 1530 
A. Transcription factors 1531 
Central to oxygen sensing in any cell is the family of hypoxia-inducible basic Helix-Loop-1532 
Helix transcription factors, the HIFs, of which there are three members, HIF-1-3 (297). 1533 
All members consist of an alpha and beta subunit, and it is the former that is oxygen 1534 
dependent. In well-oxygenated conditions this sub-unit turns over rapidly and does not 1535 
accumulate, whereas under hypoxia it is stabilized and the two subunits are able to 1536 
combine to form an effective transcription factor. This binds to hypoxia response 1537 
elements on a wide range of genes, the most important of which in the current context 1538 
include those encoding VEGF, glucose transporters and glycolytic enzymes. It can also 1539 
inhibit mTOR signaling, and hence regulate protein synthesis. The actual oxygen sensors 1540 
are the prolyl-4-hydroxylase (PHDs) enzymes that have an absolute requirement for 1541 
molecular oxygen and hydroxylate conserved proline residues on the alpha subunit. 1542 
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This enables binding of the von Hippel-Lindau protein (pVHL), which targets the subunit 1543 
for ubiquitination and subsequent degradation (493).  HIF-1 thus provides a very rapid 1544 
mechanism for responding within seconds or minutes to acute changes in oxygenation, 1545 
whereas HIF-2 is thought to mediate longer-term adaptations to relatively modest 1546 
changes (444). 1547 
 1548 
Animal studies have confirmed that HIFs are expressed at the blastocyst stage of 1549 
development (243), and that they are essential for normal placental development. 1550 
Knockout in mice results in failure of allantoic attachment with the chorion, impaired 1551 
vascularization in the labyrinth, and abnormal differentiation of the trophoblast sub-1552 
populations (161). Consistent with these effects, HIF-1 and HIF-2 have been 1553 
immunolocalized in the human placenta to the trophoblast and endothelial cells 1554 
throughout gestation (447). There has been considerable interest in the importance of 1555 
HIF signaling during the first trimester when the intraplacental oxygen concentration is 1556 
relatively low. Ontogenetic studies have reported contrasting results, with peaks of HIF-1557 
1α at 7-10 weeks and then again at 14-18 weeks (269), or a steady decline in HIF-1α 1558 
from 5-8 weeks to 18-21 weeks and a rapid decline of HIF-2α between 5-8 weeks and 9-1559 
11 weeks (447). Interpretation of these data is difficult given that it is now realized that 1560 
HIFs can be stabilized by factors other than hypoxia, including reactive oxygen and 1561 
nitrogen species, angiotensin, growth factors and cytokines (433, 444), many of which 1562 
are changing during early pregnancy. Another potential confounder is stress induced on 1563 
the tissues during collection, especially when this is performed by curettage when they 1564 
are inevitably mixed with maternal blood (112). It is notable that HIF-1 and HIF-2 are 1565 
undetectable in first trimester samples collected by a chorionic villus sampling (CVS) 1566 
technique and processed immediately (112). Thus, it is unlikely that HIF signaling plays 1567 
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a significant role under the steady state, low oxygen conditions that prevail during the 1568 
first trimester. This is supported by the observation that the ATP/ADP ratio is the same 1569 
during the first and early second trimesters and at term (112). The tissues are therefore 1570 
not energetically compromised, most likely due the high activity of glycolytic 1571 
metabolism (284). In addition, the intraplacental oxygen concentration of ~2.5% during 1572 
the first trimester exceeds the evolutionary conserved range of maximal HIF activity of 1573 
0.5 - 2.0% oxygen (225, 286).  1574 
 1575 
There is no doubt, however, that the HIF signaling machinery is competent in the human 1576 
early placenta and can respond to acute changes in oxygenation. Experiments on first 1577 
trimester placental explants cultured at 3% oxygen compared with 21% indicate that 1578 
HIF regulates trophoblast proliferation, migration and invasion through its actions on 1579 
TGFß3 (89). Equally, HIF-1 and HIF-2 can be stabilized in CVS samples by stress and 1580 
activate downstream targets, including VEGF (112).  1581 
 1582 
In later pregnancy, natural selection acting on HIF-targeted or –regulatory genes has 1583 
been implicated in mediating placental adaptations to the chronic hypobaric hypoxia 1584 
experienced at high altitude (388). Increased levels of HIF-1α mRNA and protein have 1585 
been reported in healthy placentas from pregnancies at 3,1000 m, in association with 1586 
elevated TGFß3, suggestive of stimulation of HIF-mediated pathways (606). Another 1587 
study of placentas from the same region found enhanced vascularization, consistent 1588 
with a hypoxic response, but paradoxically HIF-DNA binding was less than in the low-1589 
altitude controls (533). Analysis of the placenta after delivery only provides a single 1590 
snapshot, however, and this finding may reflect successful adaptations earlier in 1591 
pregnancy, for these placentas showed no evidence of oxidative or glycolytic stress.  An 1592 
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excessive hypoxic response may account for the increased incidence of chorangiomas in 1593 
placentas from altitudes greater than 4,000 m (459, 510), but no data are available as to 1594 
whether this is HIF-mediated.. 1595 
 1596 
Aberrant HIF signaling has been implicated in the pathophysiology of pre-eclampsia, in 1597 
particular of the early-onset form when the PHDs do not appear to sense oxygen (90, 1598 
448, 467), and may be responsible for the abnormal placental secretion of angiogenic 1599 
regulatory factors that is thought to precipitate the clinical syndrome (413).  1600 
 1601 
A number of other transcription factors and co-activators have been identified that 1602 
respond to changes in the redox potential of a cell rather than to oxygen directly. These 1603 
include AP-1, CREB, Mash2, NFκB, p53, PCC-1α, SP-1 and STAT3 (16, 106, 155, 277). 1604 
Often, activation involves conformational changes secondary to formation of disulfide 1605 
bonds, and so responses can be rapid. While some of these pathways have been 1606 
implicated in stress responses, others are involved in trophoblast proliferation and 1607 
differentiation, and secretion of extracellular matrix.  1608 
 1609 
B. Epigenetics  1610 
1. Non-coding RNAs 1611 
A large number of miRNAs have been identified from the field of cancer biology as being 1612 
regulated by hypoxia, and mediate events such as cell proliferation, differentiation, 1613 
invasion and metastasis that are relevant to placental biology (109, 499). Many of these 1614 
are miRNAS are regulated by HIF, but others are HIF-independent. The human placenta 1615 
expresses a wide variety of non-coding RNAs (398), but few data are available regarding 1616 
their responsiveness to hypoxia. Most attention has focused on mir-210, which is HIF-1617 
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dependent. It is increased in normal placentas from pregnancies at high altitude (121), 1618 
and in placentas from pregnancies complicated by pre-eclampsia (272, 351, 401, 611). 1619 
MiR-210 has a number of targets that are relevant to the placenta and developmental 1620 
programming. Within mitochondria it targets regulatory proteins that assist in the 1621 
assembly of the complexes of the electron transport chain, and suppresses respiration 1622 
(103, 108). Consistent with this action, the complexes are reduced in these high-altitude 1623 
placentas (121), as is the ATP/ADP ratio (534), suggesting energetic compromise that 1624 
could adversely affect transport and synthetic activities of the organ. Furthermore, 1625 
transfection of trophoblast cells with miR-210 reduces respiration and oxygen 1626 
consumption (401). Besides mitochondria, other targets identified for miR-210 include 1627 
the steroidogenic enzyme hydroxysteroid (17-ß) dehydrogenase 1 (272), ephrin-A3 and 1628 
homeobox-A9 which are involved in trophoblast cell migration and vascular remodeling 1629 
(611), and thrombospondin type 1 domain containing 7A in the placental vasculature 1630 
(351). 1631 
 1632 
Other micro-RNAs identified as being differentially expressed under hypoxia include 1633 
miR-93, miR-205, miR-224, MiR-335, MiR-424, miR-451 and miR-491 (396, 397), and 1634 
mIR-34a (154), but little is known regarding their functional significance at present.  1635 
 1636 
2. mRNA stability 1637 
Transcript levels are determined by both the rate of transcription and the rate of mRNA 1638 
degradation. Stability of mRNAs is regulated by association with specific binding 1639 
proteins or with micro-RNAs, and can be influenced by hypoxia. A notable example is the 1640 
mRNA encoding Angiopoietin-1, which becomes less stable under low oxygen 1641 
conditions, shifting the balance of angiopoietin-1:angiopoietin-2 in favor of 1642 
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angiopoietin-2 and vessel growth (608). By contrast, the half-life of the mRNA encoding 1643 
VEGF is more than doubled under hypoxic conditions (334), again favoring 1644 
angiogenesis. Such effects could contribute to the increased placental angiogenesis 1645 
observed under hypoxic conditions. 1646 
 1647 
3. DNA methylation and histone modifications 1648 
Hypoxia can potentially impact on DNA and histone methylation since the demethylase 1649 
enzymes are dioxygenases, and so require oxygen and 2-oxoglutarate for their activity 1650 
(501). Hence, there is the possibility of changes in chromatin structure in response to 1651 
hypoxia. The significance for the placenta is still unknown, although it is well recognized 1652 
that nuclei within the syncytiotrophoblast exhibit contrasting patterns of chromatin and 1653 
different epigenetic states (187). Nuclei that display particularly condensed chromatin 1654 
aggregate in syncytial knots and are transcriptionally inactive (188). Whether more 1655 
subtle changes regulate gene expression under different environmental conditions 1656 
awaits investigation. 1657 
 1658 
Methylation of the DNA represents another level of control, affecting promoter 1659 
availability. Methylation changes in response to intermittent hypoxia in experimental 1660 
animals have been reported (66), and the realization that 5-hydroxymethylcytosine, an 1661 
oxidation product of 5-methylcytosine, plays an important role in regulating 1662 
transcription raises further possibilities for gene-environment interactions. The heavily 1663 
condensed nuclei within syncytial knots stain particularly strongly for 5-1664 
hydroxymethylcytosine (187). 1665 
 1666 
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Epigenetics is a rapidly expanding field, and there are now many reports of changes in 1667 
placental DNA methylation and histone proteins in response to environmental cues that 1668 
have been associated with developmental programming of the offspring (203, 417, 522). 1669 
Interpreting the significance of these findings is difficult at present, since they are based 1670 
on analysis of placental homogenates. It is therefore impossible to determine in which 1671 
tissue the changes have occurred, be it trophoblast, immune cell or vascular 1672 
endothelium. It is also impossible to assess whether the changes have functional 1673 
significance for placental transport or hormone synthesis, or whether they are just 1674 
epiphenomena. The situation may be resolved as the technology advances, enabling 1675 
methylation studies to be performed on single cells or laser-capture microdissected 1676 
tissues, allowing more specific analyses to be undertaken.  1677 
 1678 
C. Mitochondrial pathways 1679 
As the principal site of oxygen consumption within cells, mitochondria likely play an 1680 
important role in oxygen sensing. There are close interactions between mitochondria 1681 
and HIF signaling that operate on a number of levels, not least because mitochondria 1682 
and the PHDs compete for molecular oxygen (523). Therefore, one or the other may be 1683 
favored depending on the precise concentration. In addition, the metabolic intermediate 1684 
2-oxoglutarate generated in the tricarboxylic acid cycle is a co-factor regulating PHD 1685 
activity (48). Another means by which the pathways may interact is through reactive 1686 
oxygen species (ROS). Mitochondria are the principal source of ROS, and production is 1687 
stimulated under both hypoxic and hyperoxic conditions. Leakage of electrons from the 1688 
complexes of the electron transport chain, in particular complexes I and III, generates 1689 
the superoxide ion, which is then converted to hydrogen peroxide. Being non-polar 1690 
hydrogen peroxide diffuses out of the organelle and can stabilize HIFs (48). In addition, 1691 
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it will influence the redox potential within the cytoplasm, and contribute to activation of 1692 
other redox-sensitive transcription factors.  It is notable that complex I and III are 1693 
downregulated at the protein level in the placenta at high altitude, which may be 1694 
interpreted as an adaptation to reduce production of ROS and so limit HIF signaling 1695 
(121). This may explain the reduced HIF-binding reported in these placentas (533). 1696 
 1697 
D. Unfolded protein response  1698 
The unfolded protein response (UPR) is a set of three evolutionary conserved pathways 1699 
whose primary function is to maintain homeostasis within the endoplasmic reticulum. 1700 
However, they are now recognized as being a point of convergence of cell responses to a 1701 
variety of stimuli, including hypoxia. Activation occurs generally at oxygen levels below 1702 
those regulating HIF (225), and although the precise sensing mechanisms are not known 1703 
there are two main possibilities. Firstly the protein disulfide isomerase enzymes that 1704 
facilitate formation of disulfide bonds during folding of nascent proteins have a 1705 
requirement for molecular oxygen as an electron acceptor. Second, the protein folding 1706 
machinery is dependent on a high concentration of Ca2+ ions within the lumen of the 1707 
endoplasmic reticulum that is maintained by SERCA pumps in the membrane. Folding 1708 
capacity may therefore be compromised if oxygen or ATP concentrations are limiting, 1709 
but this is likely to be a secondary mechanism (315).  The accumulation  of misfolded 1710 
proteins will activate the three pathways; PKR-like ER kinase (PERK), activating 1711 
transcription factor 6 (ATF6), and inositol-requiring protein 1 (IRE1). PERK selectively 1712 
suppresses formation of non-essential new proteins by phosphorylating eIF2α 1713 
(eukaryotic initiation factor 2 sub-unit alpha) and blocking cap-dependent RNA 1714 
translation. It also upregulates the transcription factor ATF4, which along with the ATF6 1715 
and IRE1 pathways selectively regulates gene expression to assist the cell to tolerate 1716 
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hypoxia (180, 343, 585). These adaptations include increased amino acid transporter 1717 
activity and enzyme expression to boost the concentration of glutathione, the principal 1718 
intracellular antioxidant, stimulation of hematopoiesis, and upregulation of the 1719 
angiogenic growth factor VEGF. However, it is now appreciated that these transcription 1720 
factors have broader targets (2), and, for example, the UPR has been implicated in 1721 
regulating processes as diverse as the inflammatory response (609) and stemness 1722 
within the intestinal epithelium (251). 1723 
 1724 
Manipulations in mice have confirmed that the IRE1 pathway is essential for normal 1725 
placental development, for knockout leads to downregulation of VEGF and abnormal 1726 
angiogenesis within the labyrinth (273). Mild activation of the UPR, with 1727 
phosphorylation of eIF2α alone, has been reported in the high-altitude human placenta, 1728 
where it may mediate homeostatic adaptations to the hypobaric hypoxia experienced 1729 
(598). More severe activation is seen in human placentas from growth-restricted 1730 
pregnancies (596), and particularly in cases of early-onset pre-eclampsia (595). These 1731 
findings can be replicated in trophoblast cell lines by exposure to hypoxia-1732 
reoxygenation, with activation of the three pathways being dependent on the severity of 1733 
the stress (596).  1734 
 1735 
The regulator eIF2α can be phosphorylated by at least three other kinases besides PERK. 1736 
One of these is GCN2, which is activated by the presence of uncharged tRNAs (153). 1737 
Hence, if either oxygen or amino acids are in short supply protein synthesis is 1738 
suppressed by a common mechanism. 1739 
 1740 
E. Ion channels 1741 
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Since ionic pumping is energy dependent, a number of ion channels are sensitive to the 1742 
prevailing oxygen concentration. Most data have been derived from the carotid body, 1743 
but may also be applicable to the placenta. The proximal sensor is still uncertain, but 1744 
two main theories have been proposed, the mitochondrial and membrane models (324). 1745 
In the former, it is proposed that under hypoxia the accumulation of ROS leads to 1746 
opening of the mitochondrial permeability transition pore and the efflux of Ca2+ from the 1747 
mitochondrial endoplasmic reticulum complex. In the latter, there are various K+ 1748 
channels that are influenced by hypoxia, including voltage-gated K+ channels, Ca2+-1749 
activated K+ channels, and ATP-sensitive K+ channels (308, 347).  Suppression of these 1750 
channels under hypoxia is thought to lead to membrane depolarization and influx of 1751 
extracellular calcium through voltage-gated calcium channels. In addition, transient 1752 
receptor potential (TRP) channels that are responsive to ROS have been identified in a 1753 
number of cell types, and provide another route of entry for calcium (589). The end 1754 
result of all these pathways is a rise in intracellular calcium, which at physiological 1755 
levels can regulate transcription of a number of genes that assist in adaptations to 1756 
hypoxia, including those encoding the ion channels themselves (347). Excessive calcium 1757 
influx can lead to activation of apoptotic and necrotic cell death, dependent on the 1758 
severity. 1759 
 1760 
A variety of K+ channel subtypes, many of them oxygen sensitive, are present in the 1761 
vasculature of the human placenta (307, 563, 564). Hypoxia-induced fetoplacental 1762 
vasoconstriction, equivalent to that seen in the pulmonary circulation, has often been 1763 
proposed but never proven (563), but could assist in matching flow in the two placental 1764 
circulations.  Voltage-dependent K+ channels have also been immunolocalized to the 1765 
syncytiotrophoblast, cytotrophoblast and some stromal cells in the first trimester and 1766 
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term placenta (382, 383), and so they may play a broader role in placental biology, 1767 
including regulating the secretion of hCG (574). In addition, Ca2+-activated K+ channels 1768 
have recently been demonstrated to be important for trophoblast syncytialization and 1769 
for syncytial volume homeostasis (145). The significance of these findings for the 1770 
expansion and functional well-being of the syncytiotrophoblast under different 1771 
environmental conditions awaits confirmation. 1772 
 1773 
F. Gasotransmitters 1774 
Allied to the functions of these ion channels are the gasotransmitters, and in particular 1775 
hydrogen sulfide. Increasing evidence suggests that this evolutionary ancient gas can act 1776 
as an oxygen sensor (423, 436). Hydrogen sulfide is generated from cysteine by two 1777 
enzymes cystathionine-γ-lyase (CSE) and cystathionine-ß-synthase (CBS). It is notable 1778 
that expression of CSE is induced by the UPR through the PERK pathway and ATF4 1779 
(146), illustrating crosstalk between these pathways. Hydrogen sulfide is metabolized 1780 
principally in the mitochondria by oxidation to thiosulfate, but if oxygen availability is 1781 
limited then the concentration in the cytosol will increase (423). There, it can activate 1782 
ATP-sensitive K+ channels with all the downstream consequences of hyperpolarization. 1783 
In addition, it can scavenge ROS and so act as a defense against ischemia-reperfusion 1784 
injury (310), affect the redox balance, and also inhibit a number of related enzymes, 1785 
including NADPH oxidase and nitric oxide synthase.  1786 
 1787 
CBS and CSE have been immunolocalized to the syncytiotrophoblast and also to the 1788 
smooth muscle cells surrounding the stem villus arteries in the human placenta (111, 1789 
262). Perfusion experiments ex vivo have demonstrated that hydrogen sulfide is a 1790 
powerful vasodilator of the fetal placental vasculature, and that its effects are mediated 1791 
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through actions on both ATP-sensitive K+ channels and nitric oxide (111). The functional 1792 
significance of the gas is reflected in the observation that downregulation of CSE is 1793 
associated with evidence of increased resistance within the umbilical circulation as 1794 
assessed by Doppler waveforms. Its role in trophoblast biology has not yet been 1795 
explored, although it is likely to impact on the redox potential within the cytosol. 1796 
Inhibition of CSE activity also inhibits trophoblast invasion from first trimester explants 1797 
in vitro, and increases the release on anti-angiogenic factors from umbilical vein 1798 
endothelial cells (559). It has been proposed that dysregulation of placental CSE activity 1799 
may contribute to the syndrome of pre-eclampsia (559). 1800 
 1801 
 1802 
VII. NUTRIENT AND ENERGY SENSING BY PLACENTAL CELLS 1803 
In the same way that placental cells are sensitive to oxygen due to their high 1804 
proliferative and metabolic rates, they are also sensitive to variations in the nutrient 1805 
supply. The available evidence suggests that they utilize pathways common to most 1806 
mammalian cells, in particular the mTOR/AKT and the AMPK pathways (Figure 10). 1807 
These networks combine with the UPR to regulate protein synthesis over the short and 1808 
long term periods to promote cell survival.   1809 
 1810 
D. mTOR/AKT pathway 1811 
The mTOR (mechanistic/mammalian target of rapamycin) complex integrates signals 1812 
from a diverse array of pathways, including oxygen- and nutrient-sensitive sensors. As it 1813 
is central to the control of cell proliferation, the complex also has strong input from the 1814 
AKT (protein kinase B) pathway that transduces growth factor stimulation. These 1815 
pathways will therefore be considered together (Figure 10).  1816 
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 1817 
mTOR comprises two major complexes, mTORC1 and mTORC2, which share the same 1818 
core kinase but have the different adaptor proteins, raptor and rictor respectively. 1819 
mTORC1 has the most direct effect on cell proliferation due to its actions on cap-1820 
dependent RNA translation mediated through phosphorylation of the binding protein 1821 
4E-BP1, and the ribosomal protein S6. In its non-phosphorylated state, 4E-BP1 1822 
modulates formation of the ribosomal complex (246), while activation of S6K1, (p70 1823 
ribosomal protein S6 kinase 1) has multiple actions. These include phosphorylation of 1824 
S6, a component of the 40S sub-unit, of regulators of translation elongation (560, 561), 1825 
and of the insulin receptor substrate (IRS) 1, creating a negative feedback loop that 1826 
limits signaling through the insulin/PI3K/AKT pathway (Figure 10). Conversely, mTOR 1827 
inhibits autophagy and other catabolic processes by promoting the ubiquitination of 1828 
ULK1 (410). Hence, stimulation of mTORC1 promotes protein synthesis, increases cell 1829 
mass and leads to cell proliferation and growth. 1830 
 1831 
mTORC1 is regulated by amino acid availability, although for many years the mechanism 1832 
has been uncertain. Early experiments revealed that withdrawal of amino acids, in 1833 
particular leucine, led to inhibition of mTOR, growth restriction and the stimulation of 1834 
autophagy. It was also clear that the amino acids acted independently of insulin, and so 1835 
were not sensed through the insulin/PI3K pathway.  More recent research has identified 1836 
a Ragulator-RAG GTPases multiprotein complex associated with the lysosomal surface 1837 
that regulates mTOR activity by controlling its sub-cellular location, recruiting it to the 1838 
lysosome (164). The membrane-resident amino acid transporter SLC38A9 is a key 1839 
component of this sensing machinery (452). 1840 
 1841 
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Glucose availability also regulates mTORC1, with accumulation of ADP and AMP under 1842 
conditions of energy shortage stimulating AMPK (AMP-activated protein kinase). AMPK 1843 
has a direct inhibitory action on raptor, the adaptor protein for mTORC1, and can also 1844 
stimulate the tuberous sclerosis complex TSC1/2 (164). TSC1/2 is a major upstream 1845 
regulator of mTORC1, suppressing activity under stress conditions. This complex plays a 1846 
major role in integrating insulin and growth factor signaling through the PI3K and AKT 1847 
pathway (Figure 10), although recent data suggest growth factors may also stimulate 1848 
mTORC1 by enhancing the delivery of amino acid-laden macropinosomes to the 1849 
Ragulator complex (593).  TSC1/2  is also responsive to hypoxia through the actions of 1850 
REDD (70). The latter involves phosphorylation of HIF-1α (88), illustrating again the 1851 
overlap between these pathways. TSC1/2 also acts on mTORC2, which in turn regulates 1852 
the activity and substrate specificity of AKT through phosphorylation (597).  1853 
 1854 
AKT is a serine/threonine protein kinase that has a wide range of targets, but the most 1855 
important for cell growth are TSC1/2 and glycogen synthase kinase 3β (GSK-3β). The 1856 
latter plays a major role in glucose homeostasis, and is likely to be key to the deposition 1857 
of glycogen in the human extravillous trophoblast cell and the murine glycogen cells. It 1858 
is also a major regulator of protein synthesis through its actions on eIF2B (568).  1859 
 1860 
The involvement of mTOR/AKT signaling in the regulation of placental growth has only 1861 
recently been addressed, but there is evidence that it is of key importance from the 1862 
earliest stages. mTOR/AKT signaling is essential for maintenance of embryonic and 1863 
hematopoietic stem cells (419), and the same is likely to be true for trophoblast. Indeed, 1864 
treatment of mouse blastocysts with rapamycin or knockout of mTOR causes lethality at 1865 
E5.5 associated with a failure of trophoblast outgrowth and maintenance of stem cells in 1866 
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the inner cell mass (206, 360). Disruption of just Akt1 causes placental and fetal growth 1867 
restriction in the mouse, with a particularly severe effect on the development of the 1868 
glycogen cells (592). Equally, a reduction of AKT and mTOR at the protein level, and 1869 
reduced phosphorylation of mTOR, TSC1/2, 4E-BP1 and GSK-3β have been reported in 1870 
growth restricted human placentas associated with maternal vascular compromise, but 1871 
there was no effect on S6Ks and eEF2K (596). Reduced p-S6K1, but no change in p-4E-1872 
BP1, was observed in placentas with growth restriction of unknown origin (468). By 1873 
contrast, increased placental mTOR signaling is associated with large for gestational age 1874 
babies delivered by obese women (279). mTOR expression is also inversely correlated 1875 
with levels of maternal exercise, and total sugar content in her diet (60). 1876 
 1877 
The effects of diet on placental mTOR signaling have been more fully explored in animal 1878 
models. Evidence from downstream signaling indicates that nutrient restriction leads to 1879 
reduced mTOR activity, along with reduced insulin and AKT signaling, in rats fed a low 1880 
protein diet (470), and mice fed 80% of the control ad libitum diet (495), as might be 1881 
expected. However, no effect was observed at mid- to late-gestation in sheep fed 50% of 1882 
the control diet (353). Data arising from over-nutrition models have been more 1883 
conflicting. Thus, whilst an obesogenic diet has been shown to cause activation of mTOR 1884 
in rat placentas (205), the opposite was found following over-nutrition in sheep (150% 1885 
of control diet) and mice fed an obesogenic diet (323, 615). 1886 
 1887 
Nonetheless, it seems reasonable to conclude that the mTOR/AKT pathway plays an 1888 
important role in matching placental growth to the available nutrient supply, an idea 1889 
originally proposed a decade ago (569). Indeed, a linear relationship between placental 1890 
mTOR activity and birth weight has been found across a wide range of maternal body 1891 
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mass index (279). In addition, the mTOR pathway regulates the activity of system A, 1892 
system L and taurine amino acid transporters in the placenta at the post-translational 1893 
level, either through modifications or by influencing translocation to the apical 1894 
membrane (469). Thus, activity of system A, but not system L, transporters in the apical 1895 
membrane of the syncytiotrophoblast correlates positively with birth weight, and may 1896 
contribute to fetal overgrowth in cases of maternal obesity (279).  1897 
 1898 
The mTOR/AKT pathway thus plays a central role in modulating anabolic and catabolic 1899 
pathways in response to fluctuations in the nutrient and oxygen supply reaching the 1900 
placenta. Such fluctuations may arise from either variations in maternal diet or 1901 
compromise of utero-placental blood flow secondary to deficient trophoblast invasion. 1902 
By regulating the activity of amino acid transporters, the pathway will also be pivotal in 1903 
integrating the maternal supply and fetal demand signals that underpin resource 1904 
allocation between the mother and her fetus. Genes encoding components of the mTOR 1905 
and protein translation pathways are amongst the most sexually dimorphically 1906 
expressed genes in the placenta (71). This could account for the different growth rates 1907 
displayed by male and female placentas, and the variations in their adaptations 1908 
observed in response to stress. Other functions, such as the regulation of extravillous 1909 
trophoblast invasion (86), have also been proposed. 1910 
 1911 
E. AMP-activated protein kinase 1912 
AMPK is an evolutionarily conserved and ubiquitously expressed regulator of cell 1913 
metabolism that is activated by depletion of ATP. Hence, it acts as a key metabolic 1914 
sensor to match energy demand with supply (240). It comprises three sub-units, each of 1915 
which have multiple isoforms and confer tissue specificity (549). Classically, it acts to 1916 
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promote glucose uptake and mitochondrial biogenesis, while reducing energy demands 1917 
by inhibiting mTORC1 (239). It may also regulate more physiological functions as it has 1918 
been implicated in stimulating endothelial nitric oxide production and regulating 1919 
vascular smooth muscle tone (219). 1920 
 1921 
Within the placental field there are limited data concerning the involvement of AMPK in 1922 
placental development and function. It has recently been implicated in controlling 1923 
uterine blood flow, and in adaptations to pregnancy at high altitude (505). Activation 1924 
has been demonstrated to be a key step in the differentiation of mouse trophoblast stem 1925 
cells under stress conditions (613), confirming that the pathway is functional in this cell 1926 
type. Knockdown of the isoforms AMPKα1 and AMPKα2 in murine SM10 trophoblast 1927 
progenitor cells has been shown to affect cell nutrient transport, inhibiting expression of 1928 
Glut3 and blocking translocation of the protein to the cell surface, but increasing the 1929 
activity of system A transporters (93). In addition, knockdown inhibits cell proliferation 1930 
and cytokine-induced differentiation. Dietary restriction (50% of controls) during early 1931 
to mid-gestation in ewes resulted in increased activation of AMPK in the fetal 1932 
cotyledonary tissues at d78 but not later on d135 (353), whereas the reverse was the 1933 
case with over-nutrition (150% of controls) (615). In the latter situation there was 1934 
reduced vascularity within the placentomes, suggesting perturbation of VEGF signaling. 1935 
Similar inhibition of AMPK signaling has been reported in the placenta of rats fed an 1936 
obesogenic diet of high-saturated fats (205).  1937 
 1938 
F. Protein synthesis inhibition 1939 
A common, immediate response of cells to oxygen or nutrient deprivation is to suppress 1940 
non-essential energy-demanding processes in order to harbor what resources are 1941 
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remaining and maximize the chance of survival. Protein synthesis represents one of 1942 
these processes, for incorporation of a single amino acid into a polypeptide chain 1943 
involves four high-energy bonds, two ATP and two GTP. Most of the data relating to 1944 
regulation of protein synthesis in response to hypoxia come from the cancer field (542, 1945 
585, 586), but it appears that the same pathways are operative in the placenta under 1946 
physiological and pathological conditions (596, 598). There are two principal 1947 
mechanisms that operate, a rapid response involving phosphorylation of eIF2α through 1948 
PERK and the UPR, and a longer term response dependent on suppression of the mTOR 1949 
pathway (181, 585). Both of these mechanisms regulate cap-dependent mRNA 1950 
translation. 1951 
 1952 
It should be appreciated that these blocks lead to a selective rather than a global 1953 
inhibition of protein synthesis. Indeed, one of the actions of the UPR is to upregulate 1954 
cellular antioxidant defenses and ER chaperone proteins, and to stimulate ER biogenesis 1955 
to increase the folding capacity and promote cell survival. Selected mRNAs must 1956 
therefore be able to bypass this translational arrest, and it has been suggested that those 1957 
containing small upstream open reading frames (uORFs) within their 5’-UTR regions or 1958 
internal ribosome entry site (IRES) sequences are able to do so (278, 349). More 1959 
recently, it has been proposed that HIF-2α is able to combine with RBM4 at hypoxia 1960 
response elements within the 3’UTR of a selective sub-set of mRNAs to initiate 1961 
translation under hypoxic conditions (539).  It is to expected, therefore, that the 1962 
secretory output of the trophoblast might change both quantitatively and qualitatively 1963 
under conditions of stress. 1964 
 1965 
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Protein synthesis is essential for normal development, and blocking dephosphorylation 1966 
of eIF2α in mice results in severe growth restriction and early embryonic lethality (241). 1967 
Equally, evidence of translational arrest has been reported in human placentas from 1968 
normal healthy pregnancies at high altitude (3,100 m) where growth of the villus tree is 1969 
impaired (598). These placentas displayed increased phosphorylation of eIF2α, reduced 1970 
phosphorylation of AKT and 4E-BP1, and an increase in total 4E-BP1 that will favor 1971 
sequestration of eIF4E. These changes can be recapitulated by exposing trophoblast cell 1972 
lines to hypoxia (1% O2), when they are associated with reduced cell proliferation. Such 1973 
mechanisms may provide the homeostatic means for matching placental and fetal 1974 
growth to the reduced ambient oxygen concentration, as previously described. The same 1975 
placentas also show a decrease in the complexes of the mitochondrial electron transport 1976 
chain at the protein, but not mRNA, level, consistent with translational arrest (121). 1977 
Indeed, treating trophoblast cell lines with salubrinal, an eIF2α-phosphatase inhibitor, is 1978 
sufficient to lower the complexes under normoxic conditions (121). There is thus a 1979 
danger of a feed-forward vicious circle developing if glycolysis is insufficient to maintain 1980 
energy levels under stress conditions. 1981 
 1982 
 Evidence of more severe translational arrest has been reported in placentas from 1983 
growth restricted pregnancies of maternal vascular origin when placental weight is 1984 
significantly reduced (596). Marked increased phosphorylation of eIF2α and decreased 1985 
phosphorylation of 4E-BP1 were observed, and more significantly, all three isoforms of 1986 
AKT were reduced at the protein, but not at the mRNA, level. Activation of the UPR has 1987 
also been reported in placentas from cases of early-onset, but not late-onset, pre-1988 
eclampsia (595), when there is often accompanying growth restriction. It is notable that 1989 
certain placental proteins, such as leptin, VEGF and its receptor soluble fms-like tyrosine 1990 
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kinase (sflt), are markedly increased in early-onset pre-eclampsia. Genomic sequence 1991 
analysis revealed that the encoding genes contain either uORFs or IRES sequences or 1992 
both. These factors may be responsible for the maternal endothelial cell activation that 1993 
typifies pre-eclampsia. 1994 
 1995 
VIII. INTEGRATION OF SUPPLY AND DEMAND AT THE PLACENTAL INTERFACE 1996 
 1997 
The placenta is not just a passive conduit for nutrient transfer. It has a dynamic role in 1998 
optimising resource allocation between the fetus and mother during pregnancy (74). 1999 
This is particularly apparent in late gestation when the fetus is growing rapidly in 2000 
absolute terms or when resources are scarce due to poor maternal nutrition or nutrient 2001 
reserves. The importance of this balance to the successful outcome of pregnancy also 2002 
depends on the total uterine mass relative to maternal body size both within and 2003 
between species, and on the particular mix of nutrients required by the fetus(es) 2004 
relative to the metabolic ability of the mother to supply these nutrients in the correct 2005 
proportions and absolute amounts (193). 2006 
 2007 
The fetus demands nutrients from the mother via the placenta to improve its fitness 2008 
since a large neonate with significant fuel reserves is more likely to survive at birth and 2009 
onto reproductive age (372). This drive is mediated partly through the expression of 2010 
imprinted genes that are expressed from paternal alleles and promote growth of the 2011 
placental tissues (42). In evolutionary terms the role of imprinting has been explained as 2012 
a means by which the male optimises the spread of his genome through the population 2013 
(391).  While the mother also benefits from this resource investment as her genes too 2014 
are transmitted to the next generation, a balance must be struck as maternal investment 2015 
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in the current fetus leaves less reserves for future pregnancies (193).  There is, 2016 
therefore, both co-operation and conflict between the mother and her fetus, and 2017 
between siblings in litter-bearing species, in resource allocation at the placental 2018 
interface (193).  This leads to adaptations in placental phenotype designed to optimise 2019 
maternal-fetal fitness with respect to the conditions prevailing during the current 2020 
pregnancy.  Changes in placental phenotype in response to environmental cues can, 2021 
therefore, be seen as a co-adaptive response mutually beneficial to the mother and fetus 2022 
in the successful outcome of pregnancy (305).  However, in the polyandrous mating 2023 
systems used by many mammals, competition between mother and fetus at the placental 2024 
level is potentially more intense because of the differing contributions to the fetal 2025 
genomes of half-siblings in demanding resources from the mother to the detriment of 2026 
other half-siblings in future pregnancies (390).  This leads to differential selection 2027 
pressures on maternally and paternally inherited alleles in the conceptus with respect to 2028 
resource allocation and is manifested as genomic imprinting, a mechanism for 2029 
monoallelically regulating gene dosage in a parent-of-origin fashion (305, 391).  2030 
Imprinted genes, therefore, have an important role in the developmental plasticity of the 2031 
placenta, particularly with respect to resource allocation (189, 445). 2032 
 2033 
Inter- and intra-species crosses between breeds of several species have shown that the 2034 
mother can constrain the fetal genetic drive for growth while, conversely, the fetal 2035 
genome can influence the mother to provide more resources with consequences for fetal 2036 
growth and pregnancy outcome (8, 457, 551).  Similarly, direct manipulation of the fetal 2037 
genome by gene deletion or disruption is known to alter resource allocation to fetal 2038 
growth via alterations in placental phenotype (198).  Thus, the placenta acts as an 2039 
environmental sensor, integrating signals of the current availability of oxygen and 2040 
 83 
nutrients, maternal stores of nutrient reserves and of the fetal nutrient demands for 2041 
growth driven by the genes and actual mass of the fetus (74, 204).  The adaptive 2042 
responses of the placenta to these signals depends on the species, stage of gestation, 2043 
total uterine mass, evolutionary history and on the specific nature of the environmental 2044 
cues (546). However, the integration of nutrient-response systems in the placenta has 2045 
not been fully determined. 2046 
 2047 
A. Hypoxia 2048 
Hypoxia is one of the most common complications of human pregnancy, occurring in 9-2049 
10% of pregnancies at sea level and all pregnancies at high altitude (484, 600).  It affects 2050 
both the placenta and fetus and is associated with impaired trophoblast invasion, poor 2051 
villous development, altered vascularity, reduced spiral artery remodelling and low 2052 
blood flow on both sides of the placenta (387, 543, 600). The placental effects of hypoxia 2053 
have been studied in a number of species using both in vivo and in vitro approaches. In 2054 
humans, the studies have concentrated on the chronic hypoxia of high altitude and 2055 
pathologies such as pre-eclampsia, whereas, in experimental animals like sheep and 2056 
mice, they have focussed more on short term, acute hypoxia at different stages of 2057 
pregnancy (255, 271, 363, 543, 600). At the placental and fetal levels, maternal hypoxia, 2058 
the diminished availability of oxygen, manifests most frequently as hypoxemia, a low 2059 
level of oxygen in the blood.   2060 
 2061 
1. Placental size, morphology and blood flow 2062 
Development of the human placenta at high altitude has been studied in populations in 2063 
Saudia Arabia, Kirghizstan, the Himalayas and in both South and North America (7, 276, 2064 
458, 532, 607, 612). These show no consistent effect of chronic hypoxia on placental 2065 
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weight or size with increases, decreases and no change depending on the study and/or 2066 
population.  Amongst studies at high altitude, the most consistent findings are 2067 
alterations in the uterine vasculature and blood flow, and an increase in fetal capillary 2068 
density in the placenta in association with fetal growth restriction. On average, there is a 2069 
100g decrease in birth weight per 1000m elevation in altitude, although the exact figure 2070 
varies with the ethnicity of the population (387).  Lower birth weight at higher altitudes 2071 
is seen with both long and short residency at high altitude regardless of nutrition or 2072 
socioeconomic class (214, 386, 389).  However, the high-altitude decline in birth weight 2073 
is less in populations with longer residency at high altitude, such as the Tibetans and 2074 
Andeans, than in populations like the Han and Europeans who have settled at altitude 2075 
more recently (214, 387, 443). These ethnic differences in birth weight have been 2076 
related to better placental adaptation to low pO2 in populations with a longer 2077 
evolutionary history at high altitude.  2078 
 2079 
Although alterations in the uterine vasculature and blood flow are a common feature of 2080 
pregnancy at high altitude, both increases and decreases in these parameters have been 2081 
reported during late gestation relative to lowland populations (387).  This is likely to 2082 
relate to differences in the ethnicity, altitude and obstetric history of the populations 2083 
studied and in the methods used to measure and calculate blood flow in the different 2084 
studies (69).  However, in the majority of studies, the normal pregnancy-induced rise in 2085 
uterine blood flow is blunted at high altitude in association with a reduced diameter of 2086 
the uterine arteries and/or lower nitric oxide synthesis, regardless of ancestry (294, 2087 
295, 577, 603, 604). This suggests that remodelling of the uterine arteries during human 2088 
pregnancy is impaired at high altitude (532), in line with the greater incidence of pre-2089 
eclampsia in these populations (429). An increase in placental weight was recently 2090 
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reported in mice exposed to 13% oxygen throughout gestation, but only in those 2091 
associated with male fetuses (363) (Table 3). Male placentas also showed more 2092 
resistance to oxidative stress, and fetal growth restriction was notably significantly less 2093 
than in their female littermates, suggesting the placentas had been able to compensate. 2094 
In pregnant sheep at high altitude, the luminal cross sectional area, but not the number, 2095 
of maternal vessels in the placentomes is increased, which results in a greater 2096 
percentage area of maternal blood vessels and normal fetal growth (317, 437).  Sheep 2097 
evolved at higher altitudes than human populations and, hence, may be better adapted 2098 
to pregnancy in hypoxic conditions (600).    2099 
 2100 
In human populations, the adverse consequences of high altitude on uterine artery 2101 
diameter and uterine blood flow are less pronounced with long than short ancestry at 2102 
high altitude (295, 387).  Pregnant Tibetan women have higher uterine artery diameters 2103 
and blood velocity than Han women at high altitude (107, 389), while Andean women 2104 
have twice the increment in uterine artery diameter during pregnancy than European 2105 
women at high altitude (295, 577, 604). This results in differences in uterine blood flow 2106 
between Andean and European women, which are detectable at 20 weeks of gestation 2107 
before fetal growth slows (295).  In some studies, the protective effect of Andean 2108 
ancestry on uterine artery haemodynamics is only seen at high altitude while in others, 2109 
the ethnic differences are also evident at sea level (295, 604).  Indeed, in Andean 2110 
women, the increase in uterine blood flow during pregnancy at high altitude can exceed 2111 
that seen at low altitude (69, 295). Thus, in some studies of Andeans, absolute oxygen 2112 
delivery to the gravid uterus at high altitude is maintained or even increased above 2113 
lowland values, despite the low maternal pO2, while in others the uterine oxygen supply 2114 
is less at high than low altitude irrespective of ancestry (69, 295, 443, 604).   However, 2115 
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for any given altitude or ancestry group, fetal size is related to the absolute rate of 2116 
uterine oxygen delivery, so weight specific rates of uterine oxygen delivery vary less 2117 
with altitude and ancestry than the absolute values (295, 604).  The fetus is, therefore, 2118 
growing in relation to its overall oxygen availability. 2119 
 2120 
At high altitude, there are also changes in the vasculature and blood flow on the fetal 2121 
side of the placenta in both humans and sheep (317, 431, 443).  In human infants near 2122 
term, the diameters of the umbilical vein and artery are both smaller at high than low 2123 
altitude, which results in a lower absolute blood flow in the umbilical circulation, 2124 
irrespective of ethnicity (295, 443).  However, babies of European ancestry are more 2125 
adversely affected than those of Andean descent (443).  In all high-altitude populations 2126 
studied to date, there is increased villous vascularisation as a result of increased 2127 
vasculogenesis and angiogenesis (7, 78, 176, 509, 532).  Depending on the study, the 2128 
increase in fetal capillary density in the human placenta may be due to an increased 2129 
capillary number, diameter or length. At high altitude, there is increased branching and 2130 
reduced coiling of the fetal capillaries in the placenta with more densely packed 2131 
capillary loops in the terminal villi responsible for gas exchange (7, 532).  The fetal 2132 
capillaries are also longer and thinner in Andean than European/Mestizo placentas 2133 
(275).  This increase in villous vascularisation at high altitude appears to occur without 2134 
any consistent increase in villous surface area or volume (176, 365, 370, 387, 458). In 2135 
addition, there is thinning of the interhemal membrane in the human placenta at high 2136 
altitude (276, 366, 458).  This is achieved through selective dilation of the capillary 2137 
sinusoids at the vasculosyncytial membranes (78), a mechanism that increases placental 2138 
diffusing capacity but has minimal effects on extracorporeal blood volume and the load 2139 
on the fetal heart. 2140 
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 2141 
Similar increases in fetal vascularity are seen in ovine placentomes at high altitude, but, 2142 
in contrast to the findings in the human placenta, these are accompanied by an increase 2143 
in the total surface area of fetal-maternal contact for gas exchange (317, 431).  In the 2144 
mouse placenta, vascularity has been shown to be increased in late gestation by 48h of 2145 
hypoxia, but decreased by longer exposures (133, 212) (Table 3).  Earlier in gestation, 2146 
there appears to be little, if any, change in placental morphology during severe hypoxia 2147 
of the mouse dam (483). In neither of these species is there evidence for thinning of the 2148 
interhemal membrane in response to hypoxic conditions (133, 317). Overall amongst 2149 
species, the morphological adaptations of the placenta will increase its oxygen diffusion 2150 
capacity and aid oxygen delivery to the fetus at low maternal pO2 (370, 387, 431).  2151 
Indeed, per kg of fetus, placental oxygen delivery to the human fetus and its rate of 2152 
oxygen consumption near term are normal at high altitude, although the fetuses are 2153 
smaller (443, 605).  Similarly, in sheep, fetal oxygen consumption is maintained when 2154 
fetal-placental hypoxia is induced by restricting uterine blood flow and, hence, uterine 2155 
oxygen delivery for 24h (53, 263). 2156 
 2157 
2. Placental metabolism and nutrient transport 2158 
In addition to the morphological adaptations in the high-altitude placenta, there are 2159 
changes in placental metabolism that may spare oxygen for onward passage to the fetus 2160 
(271).  In Bolivian women, oxygen consumption by the utero-placental tissues near term 2161 
appears to be about 20% less at high than low altitude in the absence of any change in 2162 
placental weight (605). This is greater than the 13-15% reduction in absolute uterine 2163 
oxygen delivery observed between these high- and low-altitude populations of pregnant 2164 
women (604, 605).  Measurements of absolute rates of uterine and umbilical glucose 2165 
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uptake suggest that the placenta may be using up to 60% more glucose at high altitude 2166 
(605).  The placental content of glucose and lactate also tend to be lower and higher, 2167 
respectively, at high relative to low altitude (534). In addition, in the high-altitude 2168 
human placenta, there is reduced abundance of all four complexes of the mitochondrial 2169 
electron transport system (ETS) responsible for oxidative phosphorylation (121). The 2170 
lower ATP/ADP ratio and the trend towards higher levels of the energy store, 2171 
phosphocreatine, in these high-altitude placentas also suggests that there is a greater 2172 
coupling of ATP demand to production and alternative sources of energy other than 2173 
oxidative phosphorylation at high altitude. Similarly, during in vitro studies of cultured 2174 
mouse trophoblast cells, hypoxia decreases abundance of cytochrome oxidase c, a 2175 
component of the ETS involved in generating the proton gradient used for mitochondrial 2176 
ATP synthesis (588). Collectively, these observations suggest that the chronically 2177 
hypoxic placenta at high altitude may switch from oxidative phosphorylation to a 2178 
greater dependence on anaerobic glycolysis to meet its ATP requirements, which may 2179 
increase fetal oxygen availability albeit at the expense of the fetal glucose supply (271, 2180 
403). The finding that placental mitochondrial oxygen consumption under state III 2181 
conditions (ADP stimulated) are higher in Tibetan than Han women also suggests that 2182 
these metabolic adaptions may be dependent on ethnicity and/or duration of high 2183 
altitude residency (612). 2184 
 2185 
The proposed metabolic switch in the high altitude placenta will have consequences for 2186 
fetal metabolism because, although fetal oxygen consumption is maintained on a weight 2187 
specific basis, the fetus has lower than normal glucose concentrations and uses less 2188 
glucose per kg body weight measured as umbilical glucose uptake (605).  Fetal oxygen 2189 
consumption must, therefore, be maintained by oxidation of substrates other than 2190 
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glucose, such as amino acids and/or fats, which will then reduce their availability for 2191 
other purposes (403).  Since the percentage decrease in fetal glucose delivery appears to 2192 
be greater than the percentage reduction in net fetal glucose consumption measured as 2193 
umbilical glucose uptake at high altitude (605), there may also be activation of 2194 
gluconeogenesis from lactate and amino acids by the high-altitude fetus near term.  2195 
There is an increase in the fetal arterial concentration of lactate in these fetuses, but 2196 
little is known about their rate of lactate consumption or about the rates of placental 2197 
production and delivery of lactate at high altitude (534, 605).  The reduced availability 2198 
of both glucose and amino acids for tissue accretion will, therefore, decrease fetal 2199 
growth in line with the oxygen supply.   2200 
 2201 
With shorter episodes of severe hypoxia (<48h) in pregnant sheep, there is evidence for 2202 
activation of fetal glucogenesis and increased delivery of glucose and lactate to the 2203 
placenta from the fetal circulation (230, 263, 292).   This short-term type of hypoxic 2204 
challenge also induces changes in umbilical blood flow, with increases or decreases in 2205 
flow immediately after the onset of maternal hypoxia depending on its severity (380, 2206 
524). Similarly, umbilical flow increases transiently 1-4 h after inducing placental-fetal 2207 
hypoxemia by uterine artery constriction in ewes, but then normalises as the period of 2208 
restricted uterine flow is extended to 24h or more (52, 230, 263, 380, 524).  In line with 2209 
the alterations in umbilical flow, there are changes in the placental delivery and fetal 2210 
consumption of oxygen.  Initially, fetal oxygen consumption decreases in line with 2211 
placental delivery but then recovers to normal values despite the sustained low delivery 2212 
by increasing oxygen extraction (230, 263, 380).  Placental oxygen consumption is 2213 
maintained at normal values for up to 48 h of hypoxemia (230, 263). Consequently, 2214 
there is little evidence for placental oxygen sparing in response to acute normobaric 2215 
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hypoxia in the sheep (230, 263, 380), as may occur in the human placenta in response to 2216 
the chronic hypoxia of high altitude (271). 2217 
 2218 
In contrast to oxygen, the ovine placenta appears to spare glucose for onward passage to 2219 
the fetus during acute hypoxemia as fetal glucose delivery and consumption are 2220 
maintained at the expense of utero-placental glucose consumption for periods of up to 2221 
24h (53, 230, 263, 380, 525).   In these circumstances, the normal rate of placental 2222 
oxygen consumption may be maintained by oxidation of lactate derived from the 2223 
lactacidemic, hypoxemic fetus (230, 263).  Certainly, lactate production by ovine utero-2224 
placental tissues is reduced by 24 h of placental-fetal hypoxemia induced by restricting 2225 
uterine blood flow or placental growth by hyperthermia (263, 456).  Little is known 2226 
about the changes in abundance of the glucose or lactate transporters in the ovine 2227 
placenta during hypoxic conditions (610). In the human placenta in vitro, acute hypoxia 2228 
leads to upregulated expression of the GLUT1 and GLUT3 (178, 249).  By contrast, in the 2229 
high-altitude human placenta, GLUT1 is reduced at the basal but not the microvillous 2230 
membranes, consistent with the decreased placental transfer of glucose to the fetus in 2231 
conditions of chronic maternal hypoxia (601, 605).  There is also a sex-linked decrease 2232 
in placental Slc2a1 (GLUT1) gene expression in the mouse placenta after 4 days of 2233 
maternal hypoxia in late gestation (Table 3).  2234 
 2235 
Much less is known about fetal-placental amino acid metabolism during either acute or 2236 
chronic hypoxemia. In the human placenta, concentrations of several key essential 2237 
amino acids were unaffected by altitude, with the exception of glutamine and the 2238 
antioxidant, taurine, which were higher in concentration at high altitude than sea level 2239 
(534).  However, there is evidence for a decrease in protein synthesis in the placenta of 2240 
 91 
non-native women at high altitude (598).  In human placentas in vitro, exposure to acute 2241 
episodes of hypoxia reduces expression and/or activity of accumulative  System A amino 2242 
acid transporters but increases activity of System L amino acid transport (313, 412, 2243 
547). In pregnant sheep, acute hypoxia for 4 h decreases the placental supply and fetal 2244 
use of leucine in association with a general increase in amino-nitrogen availability in the 2245 
fetal circulation and reduced rates of fetal protein synthesis and proteolysis (380). The 2246 
net effect of these changes is a reduction in protein accretion by the fetus.  In the mouse 2247 
placenta, maternal hypoxia for 2-4 days in late pregnancy leads to reduced expression of 2248 
an isoform of the y+ system of cationic amino acid transporters and increased 2249 
expression of the Slc38a1 isoform of the System A amino acid transporters (Table 3).   2250 
 2251 
Collectively, the studies show that the placenta tolerates hypoxemia well, but adapts its 2252 
metabolism and transport characteristics to cope with the reduced oxygen availability 2253 
(485).  However, its strategy appears to differ with species, duration, severity and timing 2254 
of the hypoxic insult, and/or the presence of fetal hypoxemia (393). At high altitude with 2255 
chronic maternal hypoxemia but mild fetal hypoxemia, the human placenta reduces 2256 
consumption of oxygen but increases use of glucose (271). At low altitude in response to 2257 
acute hypoxia and fetal hypoxemia, the sheep placenta maintains its rate of oxygen 2258 
consumption but reduces its use of glucose, while increasing uptake of lactate from the 2259 
fetal circulation.  In both scenarios, fetal metabolism is altered.   In the high-altitude 2260 
human fetus there is reduced glucose consumption but normal oxygen consumption, 2261 
while in fetal sheep exposed to 4 h or more of acute hypoxia, normal rates of glucose and 2262 
oxygen consumption are maintained coupled with fetal glucogenesis and altered amino 2263 
acid turnover. In both species, the changes in placental and fetal metabolism will have 2264 
adverse consequences for fetal growth.  2265 
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 2266 
3. Placental endocrine function 2267 
Both in vivo and in vitro studies have shown that hypoxia affects placental production of 2268 
a wide variety of hormones including protein, glycoprotein, eicosanoid and steroid 2269 
hormones (Table 4).  Altered placental endocrine function is seen in response to both 2270 
chronic and acute hypoxia and reflects changes in gene expression, protein synthesis, 2271 
and in metabolism and secretion of hormones (Table 4).  These endocrine changes do 2272 
not appear to be a strategy to reduce placental energy expenditure, as there are both 2273 
increases and decreases in placental hormone production (Table 4). In addition to the 2274 
endocrine outcomes of poor oxygen availability, there are also paracrine changes within 2275 
the placenta itself, which will contribute to the adaptations in its morphological and 2276 
transport phenotype (191). Furthermore, hypoxia induces changes in the placental 2277 
barrier to transfer of maternal hormones to the fetal circulation (Table 4). For instance, 2278 
in human and mouse placentas hypoxia reduces expression of 11βHSD2, potentially 2279 
compromising the inactivation of maternal cortisol and exposing the fetus to 2280 
hypercortisolemia  (133, 242). Conversely, hypoxia increases expression of the thyroid 2281 
hormone binding protein involved in transferring maternal thyroid hormones to the 2282 
human fetus (434).   2283 
 2284 
The changes in placental hormone synthesis and metabolism in response to hypoxia are 2285 
likely to have consequences for both the mother and her fetus.  They may contribute to 2286 
the observed changes in uterine and umbilical blood flows, and influence the maternal 2287 
metabolic adaptation to pregnancy during hypoxic conditions.  Certainly, the normal 2288 
pregnancy-induced increase in maternal insulin resistance associated with increased 2289 
placental production of somatotrophic and steroid hormones is absent in women 2290 
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chronically hypoxic at high altitude (316).  Studies in women and sheep at high altitude 2291 
have also shown that placental steroid production depends on the length of residency at 2292 
altitude (105, 432).  In turn, this may explain some of the ethnic differences in birth 2293 
weight seen between populations with long and short ancestry at altitude (69).  2294 
 2295 
B. Nutrition 2296 
The ability of the mother to provide nutrients to the fetus is determined, in part, by her 2297 
nutritional state. This involves her diet, body composition and fuel reserves both before 2298 
and during pregnancy, as well as her metabolic and physiological adaptations to the 2299 
pregnancy per se. In addition, maternal nutrition is a major determinant of placental 2300 
development and alters the morphological, transport and endocrine characteristics of 2301 
the placenta with consequences for the fetal nutrient supply in a wide range of species 2302 
including laboratory and farm species as well as human and non-human primates (47, 2303 
144, 204, 522, 550).  Both under- and over-nutrition during pregnancy are effective at 2304 
altering placental development in human and other species.  There are also interactions 2305 
between the current nutritional environment of the mother and her past nutritional 2306 
history, as indicated by her body mass index (BMI) and body composition, in 2307 
determining placental phenotype (29, 521, 527, 556).  In experimental animals, the role 2308 
of nutrition in regulating placental phenotype has been studied by varying dietary 2309 
composition and maternal intake of calories, macro- and micro-nutrients and of other 2310 
substances with metabolic actions such as alcohol, antioxidants and hormones (546). 2311 
These dietary manipulations have been applied to induce obesity, for example, prior to 2312 
conception and/or after establishment of pregnancy, or to investigate the effects of 2313 
more acute nutritional changes later in gestation.  In addition, changes in nutritional 2314 
state and food intake during pregnancy often accompany, and are confounding factors in 2315 
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studying, other environmental challenges such as hypoxia, heat stress, exercise and 2316 
alterations in housing, lighting and noise levels (482).  2317 
 2318 
1. Placental size, morphology and blood flow 2319 
Relative to the hypoxia of high altitude, much less is known about the effects of nutrition 2320 
on development of the human placenta.  The size of the human placenta at term is 2321 
known to be affected by the calorie intake and dietary composition during the 2322 
pregnancy (216, 350, 471).  It is also positively related to maternal BMI across the 2323 
normal spectrum, from the underweight to the morbidly obese (556).  Variations in the 2324 
balance between protein and carbohydrate intake at different stages of human 2325 
pregnancy are related to placental and infant size at birth, with reduced protein intake 2326 
in late gestation associated with a smaller placenta (216).  Women who gain weight 2327 
between pregnancies are more likely to have a large placenta subsequently whereas 2328 
those with significant inter-pregnancy weight loss are more prone to placental growth 2329 
restriction in their second pregnancy (553).  Formal fasting in late pregnancy during 2330 
Ramadan is also associated with reduced placental weight at term in Saudi Arabian and 2331 
Tunisian women (10, 12).  In the Dutch hunger winter populations, placental weight at 2332 
term was increased when the famine occurred in the 1st trimester but was reduced, 2333 
along with infant birth weight, in women who were in their 3rd trimester at the time of 2334 
the famine (350, 471).  However, despite this, placental efficiency measured as the fetal 2335 
to placental weight ratio was greater in response to the undernutrition in late pregnancy 2336 
than seen in control pregnancies before the famine (350, 471). Similar increases in 2337 
placental efficiency are seen in the human populations fasting for Ramadan and in 2338 
underweight women delivering small infants with a small placenta (10, 556). Taken 2339 
together, these observations suggest that the human placenta either has a significant 2340 
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reserve capacity or can adapt its nutrient transport capacity during nutritional 2341 
compromise to support fetal growth. There is also some evidence of changes in 2342 
angiogenesis in the placenta of obese women (157).  In non-human primates, there are 2343 
increases in placental infarction and reductions in utero-placental blood flow in 2344 
response to feeding a high fat diet, which are more pronounced in mothers that become 2345 
obese than in those who remained lean on the diet (200). 2346 
 2347 
Similar changes in placental growth and efficiency are seen in murine and ovine 2348 
placentas in response to maternal undernutrition (198, 546, 550).  In pregnant mice, 2349 
decreases in placental vascularity are seen in response to maternal obesity, calorie 2350 
restriction and feeding diets high in fat or low in protein, particularly in the labyrinthine 2351 
zone (Table 5).  There are also changes in the relative proportions of the placental zones 2352 
and reductions in surface area of the labyrinth and thickness of the interhemal 2353 
membrane in response to nutritional manipulations before, and during, mouse 2354 
pregnancy, irrespective of the level of calorie intake or maternal adiposity (Table 5).  2355 
Even relative modest changes in dietary composition within the range recommended for 2356 
rodent pregnancy can alter placental weight and zonal proportions near term (119, 2357 
301).  2358 
In sheep, undernutrition during the early stages of pregnancy when the placenta is 2359 
growing most rapidly leads to an increase in term placental weight, whereas nutrient 2360 
restriction later in pregnancy once the placenta is fully formed leads to reduced 2361 
placental weight at term (198).  These changes in weight are accompanied by alterations 2362 
in the gross morphology of the ovine placentomes and in their vascularity (454, 463).  2363 
Similar changes in placental morphology are also seen in response to overnutrition in 2364 
juvenile and adult sheep (250, 354, 454).  In particular, there are decreases in capillary 2365 
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vascular density and/or volume in the caruncular part of the ovine placentomes, 2366 
irrespective of whether the mothers were over- or under-nourished during pregnancy 2367 
(454, 463). In contrast, vascularity of the fetal cotyledonary part of the placentomes is 2368 
increased in response to undernutrition during mid-gestation (614). When over-2369 
nutrition begins before ovine pregnancy, there are increases in placentome capillary 2370 
diameter at mid-gestation that are not sustained until term (354).  In some, but not all, 2371 
studies these changes in placental vascularity are accompanied by decreases in cell 2372 
proliferation, angiogenesis and uterine and/or umbilical blood flow (166, 550, 557).  At 2373 
present, the mechanisms that regulate the responses to under- or over-nutrition are 2374 
unknown, but likely involve the mTOR pathway and/or the generation of ROS. 2375 
 2376 
2. Placental metabolism and nutrient transport 2377 
There have been relatively few studies of placental metabolism and nutrient transport 2378 
with respect to nutritional state in women. The majority have concentrated on maternal 2379 
obesity rather than on undernutrition or dietary composition. A recent study has shown 2380 
that placental expression of GLUT1 is positively related to sugar intake in normal 2381 
pregnant women (60).  System A amino acid transport activity is lower in the placenta of 2382 
women with smaller upper arm muscle areas, which suggests that reduced protein 2383 
accretion in the mother, a proxy measure of nutritional state, may limit fetal amino acid 2384 
availability (336).  Reduced taurine and System A transport activity, and lower SNAT4 2385 
expression, are also seen in placental villous fragments from obese women delivering 2386 
infants of normal birth weight (151, 184). By contrast, in obese women delivering larger 2387 
infants, placental GLUT1 expression and System A activity are higher in the basal and 2388 
microvillous membranes, respectively, than seen in women with a lean BMI (1, 279).  2389 
There are also changes in placental fatty acid transport and transporter expression in 2390 
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obese relative to lean women irrespective of the weight of their infants (101, 156).  2391 
Furthermore, mitochondrial density and expression of the electron transport chain ETS 2392 
complexes decrease in the human placenta as maternal BMI increases, with the result 2393 
that placental respiration is lower in obese than lean women (244, 376).  Taken 2394 
together, these observations suggest that nutritional state and obesity, in particular, 2395 
alter the energetics and nutrient transport capacity of the human placenta, which will 2396 
have consequences for fetal development.  However, the heterogeneity of the placental 2397 
responses to maternal obesity in relation to infant birth weight suggests that there may 2398 
be additional metabolic or other factors involved in regulating placental transport 2399 
phenotype in these circumstances. Certainly, the specific changes in placental ETS 2400 
function in obese women appear to depend, in part, on the degree of maternal glucose 2401 
intolerance (244).  2402 
 2403 
More is known about the effects of maternal nutrition on placental transport and 2404 
consumption of nutrients in experimental animals.  In pregnant mice, both under- and 2405 
over-nutrition influence the transport phenotype of the placenta in late gestation (Table 2406 
5). Even relatively minor changes in dietary composition are known to alter placental 2407 
clearance of glucose and amino acids with consequences for growth of the mouse pups 2408 
near term (119).  In part, the responses of the mouse placenta depend on the severity 2409 
and duration of the altered dietary regime, and on the degree of placental and/or fetal 2410 
growth restriction (Table 5).  For example, a 50% reduction in food intake for the 2411 
second half of mouse pregnancy leads to reduced placental glucose and amino acid 2412 
delivery and severe feto-placental growth restriction, whereas a 20% reduction in food 2413 
intake for most of pregnancy up-regulates amino acid transport per gram of placenta in 2414 
association with relatively small reductions in fetal-placental weight close to term (120, 2415 
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207).  With several of the dietary manipulations including those inducing maternal 2416 
obesity, the compromised growth and morphology of the mouse placenta is associated 2417 
with up-regulation of nutrient transport or transporter expression (Table 5).  2418 
Collectively, these studies suggest that a smaller, morphologically compromised 2419 
placenta adapts its transport characteristics to help maintain fetal growth in late 2420 
gestation (Table 5). For instance, feeding a diet high in fat and sugar reduces fetal-2421 
placental growth at day 16 of mouse pregnancy yet upregulates placental glucose and 2422 
amino acid clearance with the result that fetal weight is restored to normal by D19, 2423 
despite persisting placental growth restriction (496). However, the extent to which this 2424 
strategy is successful in altering maternal-fetal resource allocation in favour of the 2425 
mouse fetus depends on the actual nutritional and endocrine environment of the mother 2426 
and on the mass, gestational age and genetic background of her litter (74, 193, 546).  2427 
 2428 
In sheep, changes in maternal glucose levels induced by fasting, over-nutrition or direct 2429 
experimental manipulation by maternal glucose or insulin infusion alter uterine glucose 2430 
uptake and, hence, placental consumption and transfer of glucose in relation to the 2431 
transplacental glucose concentration gradient driving glucose flux (247, 557). Even 2432 
when hyperglycaemia or hypoglycaemia is prolonged in the ewe, placental glucose 2433 
consumption still varies directly with the maternal glucose concentration (99, 147). 2434 
Similarly, in overnourished obese adolescent ewes, there is no evidence for a change in 2435 
the placental glucose transfer capacity, despite feto-placental growth restriction, as 2436 
placental glucose consumption and transfer vary normally with maternal glucose 2437 
concentrations on a weight-specific basis (554).  However, in late gestation once the 2438 
sheep fetus has developed the capacity for glucogenesis, the placenta can consume 2439 
glucose from the fetal circulation if the maternal supply is limited or concentration 2440 
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gradients are manipulated experimentally (190, 194, 248).  With prolonged maternal 2441 
hypoglycaemia, distribution of uterine glucose uptake between the ovine utero-2442 
placental and fetal tissues shifts to favour the utero-placental tissues, although absolute 2443 
rates of glucose consumption remain lower than normal (99).  This too, may reflect the 2444 
ability of the sheep fetus to supplement its own glucose supply by activating 2445 
gluconeogenesis, thereby reducing its demand for maternal glucose and sparing glucose 2446 
for placental functions essential to maintaining pregnancy (148, 194). Ovine placental 2447 
GLUT expression is altered in response to longer term variations in maternal glycaemia 2448 
with decreases in GLUT1 abundance in hypoglycaemia conditions, and in both GLUT1 2449 
and GLUT 3 abundance in response to hyperglycaemia (138, 139, 247, 353).  However, 2450 
these changes may not have significant effects on glucose transport as the maximal 2451 
capacity for placental glucose transport is much greater than the actual transport rate in 2452 
the ewe (247).  2453 
 2454 
Variations in maternal nutritional state have little effect on oxygen consumption by the 2455 
ovine utero-placental tissues (99, 148, 190, 554).  Consequently, when glucose 2456 
consumption is reduced, for example by fasting, the utero-placental tissues must be 2457 
oxidising other substrates.  There are increases in the uterine uptake and utero-2458 
placental utilisation of some branched chain amino acids in response to fasting ewes, 2459 
which may provide an alternative source of energy (338).  In addition, undernutrition of 2460 
ewes from early to mid-gestation increases expression of several molecules involved in 2461 
transplacental fatty acid transport at mid-gestation, although few of these changes 2462 
persist until late gestation (353).  Certainly, there is no measureable net uptake of fatty 2463 
acids by ovine utero-placental tissues in late gestation after prolonged hypoglycaemia 2464 
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(99).  In contrast, diet-induced obesity of ewes increases expression of several fatty acid 2465 
transporters in the placenta at both mid and late gestation (616).  2466 
 2467 
3. Placental endocrine function 2468 
Changes in placental size due to variations in maternal nutrition or obesity are likely to 2469 
affect placental hormone synthesis, and hence circulating hormone concentrations.  2470 
There are reductions in maternal progesterone and estrogen concentrations in obese 2471 
women and overnourished adolescent ewes (326, 328, 555).  In the latter animals, the 2472 
decrease in maternal progesterone levels was associated with reductions in both 2473 
placental weight and expression of CYP11A1 mRNA at term compared to moderately fed 2474 
adolescent ewes (328).  In adult ewes, there are changes in the uteroplacental synthesis 2475 
and metabolism of prostaglandins in response to acute nutritional manipulations during 2476 
late gestation (195).  In particular, there is increased utero-placental production of 2477 
prostaglandins E and F2α when maternal glucose levels fall due to fasting or insulin 2478 
infusion in the ewe (192, 197).  This may reflect the switch of hypoglycaemic placental 2479 
tissues from glucose to fat metabolism, and the concomitant increase in availability of 2480 
arachidonic acid, the prostaglandin precursor (195).  Certainly, infusion of glucose into 2481 
the fasted ewes to restore normoglycemia also normalises prostaglandin output by the 2482 
uteroplacental tissues (192).  In addition, production of ovine placental lactogen (oPL) is 2483 
nutritionally responsive and is increased in late gestation by short-term fasting and 2484 
periconceptional undernutrition (421, 422). It is also increased by short-term glucose 2485 
infusion (421).  In contrast, maternal oPL concentrations are low for most of gestation in 2486 
overnourished adolescent ewes in association with placental growth restriction (328).  2487 
In the mouse, manipulation of dietary fat content during pregnancy also alters 2488 
expression of both the growth hormone gene (Gh1) and the extensive family of prolactin 2489 
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and prolactin-like genes in the placenta during late gestation (356).  However, the extent 2490 
to which any of these alterations in hormone synthesis and metabolism are due directly 2491 
to the changes in nutrient availability remains unclear, as other factors known to affect 2492 
production of these hormones, such as glucocorticoid bioavailability, are also influenced 2493 
by nutritional state (128, 191).    2494 
 2495 
C. Genetic manipulation of nutrient supply and demand 2496 
The responses of the placenta to environmental cues, such as hypoxia and nutrition, 2497 
indicate that there is significant interaction between maternal nutrient availability and 2498 
fetal demands for these resources in determining maternal-fetal nutrient allocation at 2499 
the level of the placenta (74, 144).   The specific nature of these interactions is difficult 2500 
to establish in vivo when the maternal, fetal and placental contributions to the dynamics 2501 
of resource allocation all change simultaneously, for example, in response to 2502 
undernutrition.  Consequently, gene manipulations in mice have been used to induce 2503 
more discrete changes in fetal demand relative to the placental supply of nutrients.  2504 
These studies have tended to concentrate on the imprinted genes, which are known to 2505 
have a disproportionately important role in fetal-placental development and are 2506 
involved in resource allocation more widely (126, 189, 385, 544).  However, even with 2507 
the imprinted genes, relatively few studies have examined the functional consequences 2508 
for the mouse placenta of altering its growth and morphological development in relation 2509 
to the fetal genetic demands for growth (537, 544).  2510 
 2511 
Measurements of placental nutrient transfer or transporters have been made in a 2512 
number of the genetic mutants with deletions in imprinted and other genes involved in 2513 
resource allocation (Table 6). There is often an increased fetal to placental weight ratio 2514 
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that is accompanied by up-regulation of glucose and amino acid transfer per gram of 2515 
placenta, particularly when placental growth is restricted early in mouse development 2516 
(Table 6). This helps to support fetal growth despite the reduced passive permeability of 2517 
the small, morphologically compromised mutant placenta (Table 6). Indeed, for 2518 
nutrients actively transported to the fetus, the reduced placental permeability may 2519 
enhance net transfer by preventing back-flux of nutrients into the placenta (150). 2520 
Comparison of the placental-specific Igf2P0 with the complete Igf2 null mutant 2521 
demonstrates clearly that the small placenta can become more efficient by increasing its 2522 
nutrient transfer and transporter abundance when there is a maintained drive for 2523 
growth by feto-placental tissues still expressing Igf2 (124, 125).  Even in the large H19-/+ 2524 
mutant placenta, restriction of its transport capacity by simultaneous deletion of the 2525 
Igf2P0 transcript leads to upregulation of MeAIB transport and Slc38a4 expression to 2526 
meet the larger demand of the overgrown mutant fetus, with increased Igf2 expression 2527 
in all its other tissues (14).  Since changes in placental Igf2P0 expression occur in 2528 
response to maternal undernutrition and feeding an obesogenic diet (120, 496), this 2529 
gene transcript may have an important role in adapting placental phenotype to 2530 
environmental cues.  Certainly, the changes in the placental capacity for nutrient 2531 
transfer induced by maternal undernutrition do not occur in the Igf2P0 null mutant 2532 
(495).  2533 
 2534 
When the fetal demand and supply are mismatched in the naturally small placenta, there 2535 
are changes in expression of several imprinted genes, including Igf2 in association with 2536 
sparing of the labyrinth zone, increased MeAIB and glucose transport and upregulated 2537 
expression of the Slc38a2 amino acid transporters (114).  As a result, the naturally small 2538 
placenta also supports more fetal growth per gram and maintains a normal fetal growth 2539 
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rate in late gestation (114). Similarly, when the placental supply of glucose to the fetus is 2540 
disrupted by deletion of the Slc2a3 gene, the placenta compensates by upregulating 2541 
placental amino acid transport and transporter expression sufficiently to maintain 2542 
normal fetal growth and metabolism until term (207). Furthermore, when placental 2543 
growth is restricted by glucocorticoid overexposure in the 11βHsd2-null mutant, there is 2544 
upregulation of placental amino acid transfer and transporter expression in association 2545 
with maintained fetal growth for the first 15 days of gestation (587). However, this 2546 
upregulation is not maintained into late gestation, probably due to the decreased fetal 2547 
demand associated with the direct growth inhibitory effects of excess glucocorticoids on 2548 
fetal tissues late in gestation (191, 587).  Thus, a mismatch between nutrient supply and 2549 
demand appears to drive an upregulated capacity for transplacental nutrient transport, 2550 
particularly when the placenta is small in relation to the fetal genetic drive for growth 2551 
and the mother has the ability to provide the additional nutrients.   2552 
 2553 
Conflict between the fetal demands for nutrients and the maternal capacity to supply 2554 
them may also underlie the altered transport characteristics of those mouse mutants 2555 
with placentomegaly (Table 6).  The reduced passive permeability, nutrient transport 2556 
and/or transporter expression of these mutant placentas may reflect the dominance of 2557 
maternal signals that constrain maternal-fetal resource allocation in the face of the 2558 
increased drain posed by the overgrown conceptuses in late gestation (14, 15).  There is 2559 
also evidence for inter-sibling competition for nutrients between mutant and wild type 2560 
fetuses within mixed litters, which affects the size of the wild type pups (14, 104, 124).  2561 
Taken together, these observations suggest that maternal constraint is an important 2562 
factor in regulating placental phenotype, not only when maternal nutritional resources 2563 
are limited but also when fetal demands increase rapidly in late gestation due either to 2564 
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large litter sizes or genetically induced conceptus overgrowth. Certainly, upregulation of 2565 
placental amino acid transport is maintained until D19 in mice with complete Igf2P0-2566 
null litters but not in Igf2P0 mutants of dams with mixed litters of mutants and wild 2567 
types, which have a greater total conceptus mass and, thus, demand for nutrients in late 2568 
gestation (124, 495).   In addition, variations in fetal-placental growth induced 2569 
genetically are known to alter the metabolic and endocrine environment of the dam 2570 
(439, 495). However, whether these maternal changes are a consequence of altered 2571 
placental endocrine function or alterations in fetal-placental nutrient demand remain 2572 
unknown. The placenta is, therefore, integrating maternal and fetal signals of resource 2573 
needs along with its own growth and metabolic requirements in controlling maternal 2574 
nutrient allocation to the gravid uterus. This dynamic adaptation in placental phenotype 2575 
optimises fetal fitness in the prevailing conditions while maintaining sufficient maternal 2576 
resource for lactation and subsequent pregnancies (144, 193).  2577 
 2578 
IX. POSSIBLE MECHANISMS LINKING THE PLACENTA AND DEVELOPMENTAL 2579 
PROGRAMING 2580 
 2581 
The placenta clearly plays a critical role in the maternal-fetal supply line, but it’s 2582 
potential influence on programming must be set in the context of other non-placental 2583 
candidates, including gametogenesis in both parents, fertilization, transport of the 2584 
conceptus in the oviduct, lactation and post-natal nutrition.  Attributing causation, or 2585 
even a proportion of it, to placental changes is therefore problematic, as the same 2586 
environmental insult may affect several different systems. In addition, the placental 2587 
changes may be secondary to programming within the embryo/fetus, or simply a 2588 
parallel response to the same insult independent of that of the offspring (58).  2589 
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Nonetheless, the placenta is in a key position to modulate signals coming from the 2590 
mother before they are transduced to the embryo/fetus, and can influence programming 2591 
in at least four ways (Figure 11). 2592 
 2593 
Firstly, its capacity to deliver sufficient oxygen and macro- and micro-nutrients to 2594 
sustain normal fetal growth may be impaired. This may be due to a number of causes, 2595 
but establishment of an adequate maternal blood flow to the placenta represents the 2596 
final common pathway for many in the human. The maternal circulation to the placenta 2597 
is dependent on remodeling of the spiral arteries, which in turn is reliant on invasion of 2598 
the endometrium by extravillous trophoblast cells during the first and early second 2599 
trimesters. The remodeling process is still far from understood, but brings together 2600 
genetic, endocrinological and local endometrial factors. Deficient remodeling leads to 2601 
malperfusion of the placenta, causing loss of function through oxidative and ER stress, 2602 
diminished surface area through reduced growth and increased infarction, mechanical 2603 
damage to the syncytiotrophoblast, and hypoxemia. The end result will be altered 2604 
development of the fetal organs, as seen in cases of severe maternal undernutrition 2605 
(215, 374, 565). 2606 
 2607 
Secondly, the same stresses may compromise the protective, barrier functions of the 2608 
placenta, allowing exposure of the embryo/fetus to abnormally high levels of maternal 2609 
glucocorticoids, drugs (both therapeutic and recreational), xenobiotics and pathogens 2610 
(129).  2611 
 2612 
Thirdly, the placenta secretes a variety of factors into both the maternal and fetal 2613 
circulations. Perturbation of that secretion may impact on fetal development, either 2614 
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directly or indirectly via alterations in maternal metabolism. For example, placental 2615 
prostaglandins or the release of pro-inflammatory cytokines, such as TNFα in response 2616 
to oxidative or ER stress, may influence fetal cardiovascular development through their 2617 
effects on the ductus venosus and endothelial cells respectively. Equally, placental 2618 
hormones, such as the IGFs, stimulate fetal organ growth, and impact on maternal 2619 
nutrient supply through their actions on appetite, the endometrial glands, pancreatic ß 2620 
cells and peripheral insulin resistance as discussed in section III.B. The impact of 2621 
placental release of microRNAs in exosomes is only just beginning to be explored, but 2622 
this represents another potentially powerful signaling mechanism relaying information 2623 
bidirectionally from the organ. 2624 
 2625 
Fourthly, there may be mechanical influences imposed by the placental and vitelline 2626 
vascular beds on the developing cardiovascular system (Figure 4). The resistance 2627 
offered by the extracorporeal circulations exerts a powerful influence on the 2628 
development of the entire fetal arterial tree, in addition to its effects on the heart (530). 2629 
The heart appears to be particularly vulnerable during the early embryonic and late fetal 2630 
periods of development (528), and so both the vitelline and placental must be 2631 
considered. With regards to the latter, placental surface area was found to be inversely 2632 
related to ultrasound measurements of umbilical arterial resistance in a prospective 2633 
cohort of nulliparous pregnancies (481). The effect on the developing heart will be 2634 
exaggerated in pathological pregnancies, where poor placental development is 2635 
associated with absent- or reversed-end diastolic umbilical arterial flow (513).  2636 
 2637 
It is also possible that the placenta may modify fetal growth and development by 2638 
mechanisms as yet unknown.  For example, it may provide stem cells to the mother and 2639 
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fetus, or may alter the maternal vascular tree so that nutrient flow is reduced.  Equally, it 2640 
may provide molecules that influence epigenetic alterations in the offspring, to suggest 2641 
but a few possibilities. 2642 
 2643 
All these factors will interact with the fetal drive for growth determined by its genotype, 2644 
and the outcome will depend on the timing and severity of the insult (Figure 11). Their 2645 
impact will also be influenced by the placenta’s ability to adapt and compensate, for 2646 
example by increasing vascularity, enzyme or transporter expression. There is also the 2647 
question as to whether the placenta has a functional reserve capacity, or whether it is 2648 
operating to its maximum potential in normal pregnancies. They are clearly differences 2649 
in placental efficiency within healthy pregnancies that deliver babies within the normal 2650 
birth weight range, but placental weight is an uninformative proxy measure for 2651 
placental function. At the crudest levels it does not distinguish between maternal blood 2652 
and placental tissue, and is heavily influenced by the mode of delivery and processing of 2653 
the organ (57). Quantifying physical parameters that determine the theoretical diffusing 2654 
capacity of the placenta provides a more objective assessment of placental function.  The 2655 
fact that the value expressed per kg of fetus remains constant across gestation suggests 2656 
that development of the placenta and fetus are closely interlinked (368).  But such 2657 
analyses cannot take into account changes in, for example, placental blood flows, 2658 
maternal-fetal concentration gradients, hemoglobin binding affinities, transporter 2659 
activity and placental metabolism. The speed with which these and many other 2660 
physiological adaptations on both the maternal and fetal sides can occur makes it 2661 
difficult to determine if any reserve capacity exists. There might also be detrimental 2662 
effects for the fetus of building too large a placenta for its immediate needs, as this will 2663 
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consume extra resources and place an additional burden on the extracorporeal 2664 
circulation.  2665 
 2666 
X. FUTURE RESEARCH 2667 
The placenta remains the most poorly understood and under-researched organ. One of 2668 
the biggest gaps in our knowledge is how the human trophoblast interacts with the 2669 
endometrium to establish the placenta during the first few weeks of pregnancy. The 2670 
events taking place then are of critical importance to generating the framework of the 2671 
placenta, and remodeling of the maternal circulation to perfuse it. We now know this 2672 
phase of development is stimulated and supported by the endometrial glands, but what 2673 
are the contents of those secretions, how are they regulated, and are they affected by 2674 
maternal diet? Emerging evidence suggests that the yolk sac plays a key role in the 2675 
transport of nutrients from the glands to the embryo, but what is its functional capacity, 2676 
and how does its vascularization impact on the developing heart? 2677 
 2678 
The maternal circulation becomes fully established at the start of the send trimester, and 2679 
the extent of villus regression at this time appears to be major determinant of final 2680 
placental size and shape. But how does unplugging of the spiral arteries occur? Is it 2681 
purely a mechanical event, or is it related in some way to decline of gland function, co-2682 
ordinating the switch from histotrophic to hemotrophic nutrition? Is onset of the 2683 
circulation abnormal in pregnancies complicated by early-onset pre-eclampsia or 2684 
growth restriction? Equally, little is known about the spiral arteries and growth of the 2685 
uterus during pregnancy. Are the arteries evenly distributed within the non-pregnant 2686 
endometrium, or are there regional differences that might affect placental efficiency? 2687 
Does the uterus expand symmetrically during gestation, and if so does the shape of the 2688 
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delivered placenta reflect the implantation site and its possible arterial supply? What 2689 
determines placental thickness? How do genetic interactions between the invading 2690 
extravillous trophoblast cells and the uterine natural killer cells influence birth weight 2691 
and obstetric outcome mechanistically?  2692 
 2693 
The placenta clearly receives signals from the mother regarding her nutritional 2694 
resources and reserves, and from the fetus relating to its demands, but what is the 2695 
nature of those signals and how are they integrated? Imprinted genes are important, but 2696 
what is the role of epigenetic factors and in what tissues are these mediated? The 2697 
placenta is also sending signals in the form of growth factors, hormones and potentially 2698 
exosomes, into the maternal and fetal circulations to modify the maternal ability to 2699 
support the pregnancy and fetal growth. The precise nature of these signals, their 2700 
regulation in response to environmental cues, and their effects remain to be determined. 2701 
 2702 
Answers to these, and other questions, will come in part through advances in imaging 2703 
technologies, and the ability to monitor placental development, oxygenation and 2704 
metabolism in real-time. Magnetic resonance imaging and associated techniques, such as 2705 
BOLD, promise much, but they must be capable of being applied during early pregnancy 2706 
to capture the most fundamental events in placentation.  In part, the answers will come 2707 
through better phenotyping of the neonates and of the delivered placenta, at both the 2708 
clinical and molecular levels. Longitudinal assessments of fetal growth trajectories in 2709 
utero are needed to identify which neonates are potentially subject to programming. For 2710 
the placenta, we need more information that just weight and shape at delivery. Greater 2711 
attention needs to be paid to the mode of delivery, and the collection of samples to avoid 2712 
possible artifacts (81), as well as to the sex of the placenta. Ultimately, we require more 2713 
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comprehensive phenotyping of the placenta, including quantification of structural 2714 
parameters such as surface area and interhemal distance, characterization of maternal 2715 
and fetal circulations, expression and activity levels of the different types of 2716 
transporters, measurement of endocrine function and enzyme activities, assessment of 2717 
placental metabolism and regulatory signaling pathways, and, ideally, single cell 2718 
transcriptomics and epigenetics. Such a comprehensive approach will require 2719 
multidisciplinary research groups and/or collaborations over samples, but only then 2720 
might we be able to tease apart the multiple interactions occurring during pregnancy, 2721 
and attribute causation with some degree of certainty.  2722 
 2723 
XI. Conclusion 2724 
Over the last decade, a mass of epidemiological evidence associating the gross placental 2725 
phenotype with predisposition to chronic disease has been accumulated. The statistical 2726 
associations are so strong, and have been confirmed in so many different cohorts across 2727 
the globe, that they are incontrovertible. However, the associations are complex, for they 2728 
integrate the long-term nutritional status of the mother, environmental cues and 2729 
stressors, the demands of the fetus, and development of the placenta.  The challenge 2730 
now is to elucidate the developmental mechanisms that link the placental phenotype to 2731 
chronic disease in the offspring. These may operate at different levels for different 2732 
diseases, and at different times during gestation.  2733 
  2734 
The pioneering epidemiological studies of David Barker inspired a new approach to our 2735 
understanding of chronic disease, highlighting the importance of pre-natal growth as the 2736 
foundation for a healthy body. As life expectancy continues to increase, we need to 2737 
ensure that the next generations are built optimally from the outset, so that their organ 2738 
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systems endure. The placenta plays a pivotal role in this process as it represents the 2739 
platform on which the individual is constructed. Its transience should not belittle its 2740 
importance. 2741 
 2742 
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Figure 1.  Diagrammatic illustration showing how the placenta may modulate and 
transduce environmental cues that lead to developmental programming of the fetus. The 
functional capacity of the placenta will depend on its development and its ability to 
adapt, as well as any reserve that exists. 
 
Figure 2. Diagrammatic representation of the three main processes by which materials 
can cross the interhemal placental membrane; diffusion, transporter-mediated and 
endocytosis. The nature of the mechanism involved will determine how readily the 
placenta can adapt to facilitate transport under adverse conditions. 
 
Figure 3. Diagrammatic representation of the gross morphology of the placenta and of 
the histology the interhemal membrane in the human, mouse and sheep. In each case the 
lower panel represents detail of the area outlined by the square in the upper panel. A) In 
the human, the fetal villi arise as a series of lobules (L) from the chorionic plate (CP). 
The basal plate abutting the maternal decidua (D), is thrown into a series of folds 
forming septae (S) that partially compartmentalize the placenta into lobes. Each lobe 
may contain one or more lobules. Maternal blood enters the intervillous space (IVS) 
from the spiral arteries (SA), passes between the villi and drains into the openings of the 
uterine veins on the septae. B) A single layer of syncytiotrophoblast (Stb) covers each 
villus and is generated from underlying cytotrophoblast (Ctb) cells. It is bathed by 
maternal blood in IVS from the start of the 2nd trimester onwards. Fetal capillaries (FC) 
within the stromal core (Str) invaginate to reduce the length of the diffusion pathway 
(arrowed). C) The mouse placenta is divided into an exchange labyrinth zone (LZ) and 
an endocrine junctional zone (JZ). The visceral endoderm layer of the inverted yolk sac 
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(YS) is exposed to the decidua (D) after the outer parietal layer breaks down (dotted 
line). This represents an important route of nutrient exchange during early pregnancy, 
and may continue until term. D) In the labyrinth the syncytiotrophoblast (Stb) is two-
layered, and an additional layer of sinusoidal giant cells (SGC) lines the maternal blood 
spaces (MBS). Little stromal tissue (Str) is interposed between the fetal capillaries (FC) 
and the trophoblast. E) In sheep, fetal villi (FV) interdigitate with maternal crypts within 
specialized areas of the endometrium (E), the caruncles, to form placentomes. In 
between placentomes, the trophoblast forms areolae (Ar) opposite the openings of the 
endometrial glands (EG). Histotroph from the glands is taken up by the trophoblast, 
representing another route for maternal-fetal transfer. F) Within a placentome there are 
six tissue layers interposed between the maternal (MC) and fetal (FC) capillaries; the 
maternal endothelium, maternal stromal tissue (MStr), the uterine epithelium which is 
converted into a synepithelium by the migration and fusion of fetal binucleate cells, the 
trophoblast (Tr), the fetal stroma (FStr) and the fetal endothelial cells. Differences in the 
nature of the interhemal interface mean that extrapolation of transport data from one 
species to another may not always be justified. 
 
Figure 4. The relationship between the vascular plexuses of the secondary yolk sac and 
the chorioallantoic placenta, and the developing heart.  Because these two beds account 
for a substantial portion of the total vascular impedance to flow sensed by the 
embryonic heart, poor vascularity in these organs would offer an increased load to the 
heart, altering gene expression patterns and leading to congenital defects or a 




Figure 5.  Coronary heart disease mortality in 2571 men born in Sheffield, U.K., during 
1907-1930 as a function of the placental to birth weight ratio expressed as a percentage.  
The lowest rates of death from heart disease were found among men where the 
placental weight was approximately 19% of the newborn body weight.  P=0.03. 
(Adapted from (217) with permission). 
 
Figure 6. Birth and placental weights of 17,000 live births in Unizah, Saudi Arabia. The 
points in the upper left box represent relatively low placental weights associated with 
relatively large babies, which have been defined as efficient placentas.  The lower right 
box shows low efficiency placentas where large placentas nourished low birth weight 
babies.  These two extremes of efficiency may represent different kinds of programming.  
(Adapted  from (11) with permission). 
 
Figure 7. Schematic representation of how multiple environments may give rise to 
placental metaflammation or ‘cold, smoldering inflammation’, and how this may 
predispose the fetus to chronic disease. 
 
Figure 8. In the Helsinki Birth Cohort, hypertension is related to the surface area of the 
delivered placenta, in mothers of below median height (160 cm) (p=0.002) but not for 
tall mothers (p=0.72).  (From (531) with permission, using data from (39)). 
 
Figure 9. A summary of the principal mechanisms for oxygen sensing in cells, and of the 




Figure 10. Diagrammatic summary of the principal ways by which the Unfolded Protein 
Response pathway may interact with the mTOR/AKT pathway to modulate protein 
synthesis within the placenta. Both pathways receive input at various levels regarding 
oxygen and nutrient availability, and will influence cell proliferation and growth. See 
text for details. 
 
Figure 11. Schematic summary showing how various environmental influences may 
interact with, and be modulated by, the placenta, and the consequences for 
developmental programming of the fetus. 
 
